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Zusammenfassung 
Der (Pro)reninrezeptor ((P)RR) ist ein Typ-1-Transmembranprotein 
verbunden mit dem lokalen Renin-Angiotensin-System (RAS), einem 
hormonalen System, welches in die Regulation des arteriellen Drucks und der 
Natriumhomöostase involviert ist. (P)RR hat zwei Liganden: Renin und 
Prorenin. Renin hat nach Bindung an den (P)RR eine erhöhte Aktivität und 
Prorenin erlangt enzymatische Aktivität ohne Entfernung des Prosegments. 
Wenn entweder Prorenin oder Renin mit dem (P)RR interagieren, wird die 
Angiotensin I und Angiotensin II Produktion initiiert aber auch der MAP-Kinase 
Signalweg aktiviert und zwar unabhängig von der Angiotensin II Produktion. 
Eine verkürzte Form des (P)RR assoziiert mit vakuolären H+-ATPasen; des 
Weiteren ist der (P)RR ein Adapterprotein zwischen Wnt-Rezeptoren und H+-
ATPasen. Daher ist ATP6ap2, H+-ATPase associated protein 2, ein anderer 
Name für den (P)RR. 
Die H+-ATPase ist ein Proteinkomplex aus vielen Untereinheiten der 
den transmembranären Transport von Protonen vermittelt, welcher durch die 
Hydrolyse von ATP angetrieben wird. H+-ATPasen haben zwei 
Hauptdomänen, eine zytosolische V1-Domäne und eine membranständige V0-
Domäne. H+-ATPasen kommen hauptsächlich in intrazellulären Organellen 
wie Endosomen, Lysosomen, Golgi-Apparat und sekretorischen Vesikeln vor, 
aber auch in der Plasmamembran von Zellen in  Niere, Innenohr, 
Nebenhoden und Knochen. In intrazellulären Organellen sind H+-ATPasen 
notwendig für die Ansäuerung der späten Endosomen und Lysosomen, was 
Membrantrafficking, Proteindegradation und  Proteinreifung ermöglicht. 
Plasmamembran-assoziierte H+-ATPasen haben zellspezifische Funktionen 
wie Körper-pH-Homöostase, Samenreifung, Innenohr-pH-Homöostase und 
Knochenresorption. 
Nieren exprimieren sehr stark H+-ATPasen in der Plasmamembran des 
proximalen Tubulus (PT), der Schaltzellen (IC) und in Membranen 
intrazellularer Organellen. Daher sind H+-ATPasen in der Niere in 
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verschiedene Funktionen involviert, wie Endozytose, Membranprotein-
Recycling sowie auch in die Ansäuerung des Urins und die Reabsorption von 
Proteinen mit geringem Molekulargewicht, Bikarbonat und Salz. 
(P)RR/ATP6ap2 ist in der Niere ebenfalls hoch exprimiert und an den 
gleichen Orten wie H+-ATPasen lokalisiert. Jedoch ist die funktionelle 
Bedeutung der Koexpression von (P)RR und H+-ATPase im Nieren PT 
momentan unklar. Diese Dissertation beabsichtigt die Funktion von 
(P)RR/ATP6ap2 in der Niere, besonders im PT, zu evaluieren und zu 
verstehen. 
Im ersten Kapitel charakterisierten wir die Expression des 
(P)RR/ATP6ap2 entlang des Nephrons der Mausniere. Wir konnten mit semi-
quantitativer real-time PCR (qRT-PCR) zeigen dass Atp6ap2 mRNA entlang 
des gesamten Nephrons exprimiert wird, mit höherer Expression im 
Verbindungstubulus/kortikalen Sammelrohr (CNT/CCD) und im äußeren 
medullären Sammelrohr (OMCD). Anschliessend haben wir mittels 
Immunohistochemie die Lokalisation von ATP6ap2 zusammen mit der a4-H+-
ATPase-Untereinheit im proximalen Tubulus gezeigt und die subzelluläre 
Lokalisation von (P)RR/ATP6ap2 in Schaltzellen untersucht. Wir konnten 
aufzeigen, dass der (P)RR/ATP6ap2 ausserdem der Expression der H+-
ATPase- Untereinheit a4 in diesen Zellen folgt. Um das H+-ATPase Trafficking 
und die Koregulation von (P)RR unter Bedingungen von Säure-Base- oder 
Elektrolytänderungen zu untersuchen, behandelten wir Mäuse mit NH4Cl, 
NaHCO3, KHCO3, NaCl oder dem Mineralocorticoid DOCA für sieben Tage. 
Wir konnten zeigen, dass der (P)RR/Atp6ap2 und die H+-ATPase-
Untereinheiten a4 und B1 weder auf dem Protein- noch auf dem mRNA-Level 
koreguliert sind. Desweiteren konnten wir mittels Immunohistochemie mit 
Nierengewebe von Kontrollmäusen, NH4Cl- oder NaHCO3-behandelten 
Mäusen zeigen, dass der PRR/ATP6ap2 mit H+-ATPase-Untereinheiten in der 
Bürstensaummembran von proximalen Tubuli, dem apikalen Pol von Typ-A 
Schaltzellen und in der basolateralen und/oder apikalen Membran von nicht-
Typ A Schaltzellen immer kolokalisiert ist. Mikroperfusion von isolierten 
kortikalen Sammelrohren und luminale Applikation von Prorenin stimulierten 
die H+-ATPase-Aktivität nicht akut. Unsere Ergebnisse zeigen, dass der 
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PRR/ATP6ap2 möglicherweise einen Komplex mit der H+-ATPase im 
proximalen Tubulus und in Schaltzellen bildet und dass Prorenin keinen 
akuten Effekt auf die H+-ATPase-Aktivität in Schaltzellen hat.  
Im zweiten Kapitel untersuchten wir die (P)RR/ATP6ap2-Funktion im 
proximalen Tubulus mittels zweier verschiedener Tiermodelle: einem 
Rattenmodell mit induzierbarer shRNA für Atp6ap2 und eine induzierbare 
Nierenepithel-Zellspezifische knockout Maus für (P)RR/ATP6ap2. Im 
proximalen Tubulus sind H+-ATPasen an der Rezeptor-vermittelten 
Endozytose beteiligt, welche die Reabsorption von Proteinen mit geringem 
Molekulargewicht durch Megalin/Cubilin Rezeptoren gewährleistet. Wir 
postulierten, dass (P)RR/ATP6ap2 wichtig ist für die H+-ATPase-Funktion in 
der Rezeptor-vermittelten Endozytose und somit auch für die Funktion des 
proximalen Tubulus. Wir zeigten, dass genetische Deletion von 
(P)RR/ATP6ap2 im proximalen Tubulus in Ratten und Mäusen Albuminurie 
und Proteinurie von Proteinen mit geringen Molekulargewicht verursacht. Um 
den endozytotischen Weg genauer zu untersuchen, wurden beide 
Tiermodelle mit einem Marker für Flüssigphase Endozytose (10 kDA Dextran-
FITC) und Rezeptor-vermittelte Endozytose (humanes Transferrin) injiziert. 
Die Endozytose von injiziertem Dextran-FITC war normal, wohingegen die 
Prozessierung von rekombinantem Transferrin zu den Lysosomen verzögert 
war. Dieser Effekt ging mit reduzierter Expression verschiedener H+-ATPase-
Untereinheiten, Akkumulation der LC3-B Untereinheit des Autophagosomens 
und reduziertem mTOR-signaling einher. Folglich ermöglicht (P)RR/ATP6ap2 
die Rezeptor-vermittelte Endozytose, womöglich durch Modulation von H+-
ATPasen im proximalen Tubulus und ist wichtig für die normale lysosomale 
Funktion.  
Zusamemnfassend präsentiert diese Dissertation neue Belege dafür, 
dass der (P)RR/ATP6ap2 an der Regulation der Nierenhomöostase im 
proximalen Tubulus beteiligt ist. Weiterhin zeigen wir, dass der 
(P)RR/ATP6ap2 für die Funktion von Lysosomen und des Autophagosomes 
relevant ist, und dies möglicherweise aufgrund der Interaktion mit H+-
ATPasen. Diese Rolle von (P)RR/ATP6ap2 in der zellulären Homöostase 
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scheint auch in anderen murinen Zelltypen wichtig zusein, wie Podozyten, 
Kardiomyozyten und Schaltzellen. Es gleicht auch Funktionen in anderen 
Organismen wie Drosophila und Zebrafisch. All diesen Beispielen ist die 
Interaktion von (P)RR/ATP6ap2 mit H+-ATPasen gemeinsam. Deshalb 
untermauert diese Dissertation ausserdem die potentielle, universale, 
zelluläre Rolle von (P)RR/ATP6ap2 und wir schlagen vor, dass die Regulation 
der Funktion von H+-ATPasen vielleicht eine, wenn nicht die Hauptfunktion 
des (P)RR/ATP6ap2 ist.   
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Abstract 
The (Pro)renin receptor or (P)RR is a type one transmembrane protein 
linked to the local renin-angiotensin system (RAS), a hormonal system 
involved in arterial pressure regulation and sodium homeostasis. (P)RR has 
two ligands: renin and prorenin. Upon binding to (P)RR, renin has its activity 
increased and prorenin gains enzymatic activity without removal of the pro-
segment.  When either prorenin or renin interact with the (P)RR, angiotensin I 
and angiotensin II production is initiated but also MAP kinase signaling is 
triggered even independent from angiotensin II production. A truncated form 
of the (P)RR has been shown to associate with vacuolar H+-ATPases; 
furthermore, the (P)RR is an adaptor protein between Wnt receptors and H+-
ATPase. Hence, another name for the (P)RR is ATP6ap2 for H+-ATPase 
associated protein 2. 
The H+-ATPase is a multi-subunit protein complex that mediates the 
transport of protons driven by hydrolysis of ATP. H+-ATPases have two main 
domains, a cytosolic V1 domain, and a membrane-inserted V0 domain. H+-
ATPases are mainly located in intracellular organelles like endosomes, 
lysosomes, golgi apparatus and secretory vesicles but it can also be found in 
the plasma membrane in cells in kidney, inner ear, epididymis, and bone. In 
intracellular organelles, H+-ATPases are fundamental for acidification of late 
endosomes and lysosomes allowing for membrane trafficking, protein 
degradation, and protein maturation. Plasma membrane H+-ATPases carry 
cell specific functions such as regulation of body pH homeostasis, sperm 
maturation, inner ear pH homeostasis, and bone resorption. 
Kidneys express very high levels of H+-ATPases in the plasma 
membrane of proximal tubules (PT), intercalated cells (IC), and in membranes 
of intracellular organelles. Therefore, H+-ATPases in the kidney are involved 
in multiple functions such as endocytosis, membrane protein recycling as well 
as urine acidification and reabsorption of low molecular weight proteins, 
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bicarbonate, and salt. The (P)RR/ATP6ap2 is also highly expressed in the 
kidney sharing the same locations with H+-ATPases. However, the functional 
significance for (P)RR and H+-ATPase co-expression in the kidney PT is 
currently unclear. This thesis aims to evaluate and understand the function of 
the (P)RR/ATP6ap2 in kidney, in particular in the PT. 
In chapter 1 we characterized thoroughly (P)RR/ATP6ap2 expression along 
the mouse nephron. We could show using semi-quantitative real-time PCR 
(qRT-PCR) that Atp6ap2 mRNA is expressed along the entire nephron with 
higher expression in the connecting tubule/ cortical collecting duct (CNT/CCD) 
and outer medullary collecting duct (OMCD). Next, using 
immunohistochemistry, we demonstrated localization of the (P)RR/ATP6ap2 
together with the a4 H+-ATPase subunit in the proximal tubule and studied 
subcellular localization of the (P)RR/ATP6ap2 in intercalated cells. We could 
demonstrate that the (P)RR/ATP6ap2 also follows H+-ATPase subunit a4 
expression in these cells. To investigate H+-ATPase trafficking and co-
regulation of the (P)RR/ATP6ap2 under conditions of acid-base or electrolyte 
changes, we treated mice with NH4Cl, NaHCO3, KHCO3, NaCl, or the 
mineralocorticoid DOCA for 7 days. We could demonstrate that the 
(P)RR/Atp6ap2 and H+-ATPase subunits a4 and B1 are not co-regulated at 
protein and mRNA levels. However, immunohistochemistry using kidney 
tissues from control, NH4Cl or NaHCO3 treated mice allowed us to 
demonstrate that (P)RR/ATP6ap2 with H+-ATPase subunits always 
colocalized at the brush border membrane of proximal tubules, the apical pole 
of type A intercalated cells, and at basolateral and/or apical membranes of 
non-type A intercalated cells. Microperfusion of isolated cortical collecting 
ducts and luminal application of prorenin did not acutely stimulate H+-ATPase 
activity. Our results suggest that the (P)RR/ATP6ap2 may form a complex 
with H+-ATPase in proximal tubule and intercalated cells and also that 
prorenin has no acute effect on H+-ATPase activity in intercalated cells.  
In chapter 2 we investigated the function of the (P)RR/ATP6ap2 in the 
proximal tubule using two different animal models. A rat model with an 
inducible shRNA for Atp6ap2 and an inducible kidney epithelial cell-specific 
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knockout mouse for the (P)RR/ATP6ap2. The latter model resulted in a partial 
deletion of the (P)RR/ATP6ap2 which was mostly occurring in proximal 
tubules but left (P)RR/ATP6ap2 expression in intercalated cells widely intact. 
In the proximal tubule, H+-ATPase are involved in receptor-mediated 
endocytosis allowing for the reabsorption of low molecular weight proteins via 
the megalin/cubilin receptors. We hypothesize, that the (P)RR/ATP6ap2 is 
important for H+-ATPases function in receptor mediated endocytosis, being 
also important for proximal tubule function. We reported that genetic deletion 
of the (P)RR/ATP6ap2 from the proximal tubule in rats and mice causes 
albuminuria and low molecular weight proteinuria. To study in more detail the 
endocytic pathway, we injected both animal models with a marker for fluid 
phase endocytosis (10 kDA Dextran-FITC) and receptor-mediated 
endocytosis (human transferrin). Endocytosis of injected Dextran-FITC was 
normal whereas processing of recombinant transferrin to lysosomes was 
delayed.  This defect was paralleled by reduced expression of several H+-
ATPases subunits, accumulation of the LC3-B subunit of the autophagosome 
and reduced mTOR signaling. Thus, the the (P)RR/ATP6ap2 facilitates 
receptor-mediated endocytosis in the proximal tubule possibly by modulating 
H+-ATPases and is important for normal lysosomal function.  
Overall this thesis presents new evidence for (P)RR/ATP6ap2 function 
in the proximal tubule in regulating kidney homeostasis. It further suggests 
that the (P)RR/ ATP6ap2 is relevant for lysosomal/ autophagy function and 
that this role may be due to the interaction with H+-ATPases. This role of 
(P)RR/ATP6ap2 in cellular homeostasis seems to be consistent with data 
from other murine cell types such as podocytes, cardiomyocytes and 
intercalated cells. It parallels also functions in other organisms like drosophila 
and zebrafish. In all these examples the interaction of the (P)RR/ATP6ap2 
with H+-ATPases is common. Thus, this thesis additionally corroborates this 
potential universal cellular role of the (P)RR/ATP6ap2 and suggests that the 
regulation of H+-ATPase function may be one if not the major function of the 
(P)RR/ATP6ap2.   
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1.Introduction 
1.1 Kidney: overview of the nephron segments 
 The kidney plays an essential role in maintaining body homeostasis via 
the regulation of electrolytes, acid-base balance, and blood pressure 
regulation. It achieves this vital function by filtering blood and excreting 
metabolic waste. The functional unit of the kidney is the nephron that is 
organized in several distinct segments (Figure 1). The nephron consists of the 
glomerulus, the proximal tubule (PT), the loop of Henle, and the distal tubule. 
Different tubular segments present different ultrastructures, different cell types 
and even different transporters according to their specific functions.  
 
 
The glomerulus and Bowman's capsule are part of the kidney filtering 
unit, localized at the beginning of the nephron. Blood is filtered through 
glomerular capillaries into the space of Bowman’s capsule. The glomerular 
filtration barrier has three components: capillary endothelium, basement 
membrane and podocytes. Podocytes are highly differentiated cells lining the 
outer part of the glomerular capillaries facing the Bowman’s capsule 1. From 
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the capillary endothelium to the podocytes, the strigency of the filtration 
barrier increases, allowing the passage of cationic molecules, electrolytes and 
small and intermediate solutes like urea (60 Da) and glucose (180 Da). This 
barrier is then selective according to molecular size, electrical charge but also 
molecular radius. Plasma cells and higher molecular weight plasma proteins 
(cut off limit for passage of proteins is	60 kDa) are retained by the glomerular 
filtration barrier 2,3. In physiological conditions a small amount of intermediate 
molecular weight proteins like albumin (66 kDa) and  transferrin (81 kDa) are 
allowed to pass the glomerular filtration barrier to a limited extent while all low 
molecular weight proteins (between10- 40 kDa) have less restrictions in their 
passage through the filtration barrier 4. 
Following the glomeruli is the proximal tubule (PT), which can be 
segmented according to its gross anatomy into convoluted PT and straight 
PT. The PT is responsible for reabsorbing the bulk of the ultrafiltrate that 
passes through the glomerular filter. Due to its reabsorbing functions PT cells 
exhibit a well-developed apical brush border membrane (BBM), tight 
junctions, abundance of large mitochondria, an enriched endosome system, 
and infoldings at the basolateral side 5. This segment will be discussed in 
more detail in section 1.2. 
The proximal tubule progresses to the loop of Henle (LOH), which can 
be further subdivided into thin descending and ascending limbs of LOH and 
thick ascending limb of LOH (TAL). The LOH segment is the nephron part 
responsible for creating a cortico-medullary concentration gradient, which in 
turn makes possible to concentrate urine. 
The distal tubule is the part of the nephron between the LOH and the 
collecting duct system (CD). The distal tubule is constituted by the distal 
convoluted tubule (DCT) and the connecting tubule (CNT). The CD system 
consists of a number of tubules and ducts that connect nephrons to the pelvis. 
This region is responsible for fine-tuning urine concentration, regulating pH 
body homeostasis and is target for several hormones like aldosterone. The 
CD is characterized by three cell types based on ultrastructure features, 
transporters composition and function. These cell types are: principal cells 
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(PC), intercalated cells type-A (IC-A) and type-B (IC-B). PCs are the majority 
of cells and play a role in water and electrolyte balance while intercalated cells 
are mostly responsible for acid-base excretion. IC-A is more common in the 
outer medulla, whereas IC-B are restricted to the renal cortex.  
From the CD, filtrate is collected into the pelvis and ureter and finally 
proceeds to the bladder. 
1.2. Proximal tubule 
1.2.1 The Structure of the Proximal tubule 
The PT can be further segmented according to its ultrastructure. The 
first segment (S1) is located in the initial part of the convoluted PT, the second 
segment (S2) spans between the end of the convoluted PT and beginning of 
straight PT and finally the third segment (S3) is located in the remaining 
straight PT. S1 cells are characterized by taller BBM, abundant mitochondria 
and vacuolar system (mainly endosomes and lysosomes) and several ridges 
in both the basal and lateral side. S2 cells share a few characteristics with the 
S1 segment cells but S2 cells have a reduced amount of mitochondria, 
vacuolar system and darker lysosomes. The S2 cell structure, as it can be 
observed in Figure 2, reflects a transition between S1 to S3 segment. S3 cells 
show smaller, lesser number of mitochondria with random distribution, less 
number of vacuoles and a prominent number of peroxisomes.  
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The PT segment ultrastructure reflects its function 5,6.Thus, the S1 
segment is concerned with solute reabsorption via sodium dependent 
transporters, which requires a high reabsorption surface demonstrated by the 
well-developed brush border membrane and the presence of abundant 
mitochondria for energy demanding transport. The segments S2 and S3 also 
contribute to solute reabsorption but their main function is in the excretion of 
xenobiotics. Therefore, segments S2 and S3 play an important role in the 
kidney detoxification functions.  
1.2.2 Functions of the Proximal Tubule: Low molecular weight 
proteins retrieval 
The PT plays a fundamental role in reabsorbing filtered ions and 
solutes like glucose and amino acids through its well-developed brush border 
	 15 
membrane and polarized transport system. The PT is also responsible for 
reabsorbing low molecular weight proteins (LMWPs) like: albumin (66 kDa), 
transferrin (81 kDa), as well as hormones like parathyroid hormone (6 kDa) 
and insulin (5,8 kDa) but also vitamin carriers like retinol binding protein (21 
kDa) or vitamin D binding protein (55 kDa), enzymes such as α-amylase (55 
kDa), immunoglobulin light chains and cell surface antigens 7. Considering 
that final urine is almost devoid of proteins, PT reabsorbs and metabolizes an 
extensive amount of LMWPs. LMWPs uptake by the PT is mainly via 
receptor-mediated endocytosis, clathrin-dependent endocytosis and possibly 
by fluid-phase endocytosis 8-10. A general overview of receptor- mediated 
endocytosis is represented in figure 3. 
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1.2.3 General structure of the apical endocytic pathway in the 
proximal tubule 
The  key features of the endosomal organization are common to all cell 
types. Internalization of cargos begins with membrane invagination following 
either a clathrin-dependent, a caveolin-dependent or a clathrin- and caveolin-
independent internalization. Thus, glomerular filtrate reaches the PT BBM 
where it is internalized. Subsequently, internalized cargo arrives at early 
endosomes where it is sorted either back to membrane (recycling pathway) or 
moves to the next compartments, the late endosomes. Late endosomes fuse 
transiently with lysosomes to deliver cargo for degradation (degradative 
pathway) 11,12. From early endosomes to lysosomes, this vesicular system 
goes through several steps of maturation, transformation, fusion and fission. 
Lipid content and protein content changes according to each step in a 
transient fashion. Small GTP binding proteins termed Rabs are sequentially 
recruited onto these compartments regulating formation, transport, tethering, 
targeting and fusion of vesicular compartments. Rabs switch determines the 
compartment identity along the endocytic pathway. For example in most of the 
cells Rab5 is characteristic of early endosomes while Rab7 is localized in the 
late endosomes 11,13,14. 
The present knowledge about the organization of the proximal tubule 
apical endocytic machinery comes from studies using immortalized and 
primary cell culture models of proximal tubules, but also from in vivo studies 
using filtered fluid phase and receptor mediated markers 15-18.. In these 
studies, rats, mice or rabbits were administered intravenal injections of 
markers for the receptor-mediated and fluid phase endocytosis, and kidneys 
were fixed at different time intervals to visualize the markers progression 
along the endocytic pathway 19-23. Briefly, these studies showed that: 
ü Initially both fluid phase and receptor-mediated markers are internalized 
into clathrin coated structures located at the base of BBM microvilli. 
ü These vesicles then lose their clathrin coating and fuse with dense 
subapical network of tubules. 
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ü Within 1 to 15 min, both markers are trafficked to a larger vacuolar 
compartment called apical vacuoles.  
ü Receptors that are recycled back to the membrane travelled from the 
subapical tubule and from apical vacuoles while its respective ligands go 
to lysosomes for degradation. The structure of the lysosomes changes 
from species to species and according to the PT segment. 
 
1.2.4 Receptor-mediated endocytosis in proximal tubule: 
megalin and cubilin. 
Receptor- mediated endocytosis in the PT relies on a low affinity, high 
capacity system, represented by its two main membrane receptors: megalin 
and cubilin 24-27. Ligands bound to megalin or cubilin are internalized as a 
receptor-ligand complex, in the endosomes upon acidification ligands are 
separated from megalin and cubilin. Ligands are usually transferred to 
lysosomes and the receptors are recycled back to the proximal tubule apical 
membrane. 
Megalin is a large glycoprotein (approximately 600 kDa) that belongs to 
the low-density lipoprotein receptor family and is present in several plasma 
membranes and in the endocytic apparatus of epithelial cells. Megalin is 
characterized by a large extra-cellular domain containing three types of 
repeats:  four cysteine-rich complement repeats interspaced by growth factor 
repeats and one epidermal growth factor like repeat (figure 4). The extra-
cellular domain is followed by a single transmembrane domain and a small 
(209 amino acid) cytoplasmic domain which contains two endocytic motifs 
NPXY which mediate uptake via clathrin coated pits and a NPXY like motif 
(NQNY) involved in megalin apical delivery 28-30. Megalin also contains a 
RXRR motif, which is a target for proteases like furin, leading to secretion of 
megalin into urine 31. Besides that, megalin can undergo intramembrane 
cleavage initiating signaling cascades 32,33. 
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Cubilin shares the same localization of megalin in the BBM of PT and 
apical endocytic compartments. Cubilin is also known as the intestinal factor 
B12 receptor 34,35. Cubilin is a 460 kDa glycosylated protein containing 23 
complement sub-component domains (CUB) and no transmembrane domain 
or cytoplasmic domain. The latter implies that cubilin needs to interact with 
other proteins in order to be positioned at the outer surface of the plasma 
membrane and to function in endocytosis. Megalin is thought to be the main 
interacting partner forming a two-receptor complex 36,37. Cubilin trafficking to 
the apical membrane is also dependent on another 38-50 kDa single 
transmembrane protein called amnionless. This functional link was proven in 
vivo in dogs containing mutations in ammnionless, amnionless deficient mice 
and patients with Imerslund-Gräsbeck syndrome that showed intracellular 
accumulation of cubilin 38,39.  
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Megalin and cubilin in the PT have functions that are directly connected 
to protein/ligand re-uptake from the filtrate. Table 1 shows some main ligands 
for megalin and cubilin in the PT. Megalin and cubilin are involved in vitamin 
metabolism like for vitamin D in which vitamin D is reabsorbed together with 
its carrier vitamin D binding protein and activated after transfer to 
mitochondria 40. Megalin is also a receptor for the degradation of parathyroid 
hormone playing a role in calcium and phosphate metabolism.  
Megalin is also involved in lysosome biogenesis, by allowing lysosome 
enzymes like cathepsin B reabsorption and delivery to lysosomes where the 
proenzyme can become functional 41.  
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The importance of megalin and cubilin is well illustrated by knockout 
animal models. Constitutive knockout megalin mice model, die after birth with 
pulmonary complications, brains defects and a decreased proximal tubule  
endocytosis machinery 42. In a conditional knockout of megalin in the proximal 
and distal tubules, mice did not show major proximal tubule cellular structure 
difference. However, knockout mice had a reduced number of coated pits, 
endosomes, and lysosomes in comparison with control animals. These 
animals also excreted LMWPs in the urine like lipophilic vitamin carriers43. 
Later, a role for megalin in calcium and phosphate homeostasis was 
established 27,44-46. Similarly, studies in pronephros of zebrafish deficient for 
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megalin showed that fluid phase endocytosis was abolished, endocytic uptake 
was affected and the structure of the endocytic apparatus was changed 47. In 
a study with cubilin cre-lox deleted mice, cubilin was shown to be important 
for amnionless expression and for albumin uptake in the PT 48. Megalin and 
cubulin ligands are described in more detail in table 1. In this thesis, we 
worked with ligands that are internalized by both megalin and cubilin (albumin 
and vitamin D binding protein), but also ligands that are specifically 
transported by megalin (procathepsin B) and by cubilin (transferrin). 
1.2.5 Proximal tubule dysfunctions in humans 
The general dysfunction of the proximal tubule is a clinical syndrome 
called De Toni-Debré-Fanconi syndrome, which is characterized by loss of 
glucose, amino acids, bicarbonate, phosphate and LMWPs in the urine. De-
Toni-Debré-Fanconi syndromes can be classified as congenital disorders 
such as Dent`s disease, Lowe`s disease and cystinosis or can be acquired as 
a result of toxin or drug exposure 27,49. Clinical symptoms of De-Toni-Debré-
Fanconi Syndromes are a result of solute or LMWPs wasting, like 
osteomalacia and metabolic acidosis. 
Dent’s disease is a rare X-linked genetic disease which can be divided 
into Dent’s 1 and Dent`s 2 49,50. Dent`s 1 was found to be associated with 
mutations in the CLCN5 gene, which encodes for a proton/chloride exchanger 
required for endosome acidification 50-52. The disease mechanism of Dent`s 1 
was elucidated by studies using knockout animals for the CLC-5 exchanger. 
These animals showed tubular proteinuria due to endosomal acidification 
impairments and decreased expression of megalin and cubilin in PT BBM 
50,53-56. In these animals a decreased urinary excretion of megalin (megalin 
sheeding) was observed which was also seen in Dent’s disease patients. 
Dent`s 2 patients have mutations in the OCRL gene which encodes an inositol 
5-phosphatase. Lowe syndrome patients also have mutations in OCRL but 
display extra renal symptoms like congenital cataracts and mental disabilities. 
OCRL was shown to be localized in several endocytic compartments and to 
be important for megalin recycling 57. 
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Proximal tubule proteinuria can also be a consequence of direct 
mutations in megalin and cubilin genes as for rare genetic diseases like 
Imerslund-Gräsbeck syndrome and Donnai Barrow Syndrome. The first 
disease is characterized by the incapacity to absorb vitamin B12 in the small 
intestine due to mislocation of cubilin. The second syndrome is a facio-oculo-
acoustico-renal syndrome caused by mutations in the megalin gene (LRP2) 
leading to the absence of a functional megalin protein.   
Cystinosis is a rare autosomal genetic disease belonging to the 
lysosomal storage diseases group, that is caused by mutations in CTNS, a 
lysosomal cystine transporter. Fanconi syndrome is one of the first 
manifestations of cystinosis. A recent study in human proximal tubular 
epithelial cells deficient for the CTNS gene revealed a potential mechanism 
that could lead to Fanconi syndrome. These cells showed an impaired 
endosome machinery, reduced expression of megalin associated with 
reduced trafficking and accumulation of lysosome cargos 58. 
1.3. The (Pro)renin receptor / ATP6AP2 
The renin angiotensin system (RAS) is a hormonal system involved in 
arterial pressure regulation and sodium homeostasis 59. Renin is an aspartic 
protease that performs the rate limiting step of the RAS by enzymatically 
cleaving angiotensinogen to angiotensin I. Renin is produced as an inactive 
precursor, prorenin, which contains a pro-segment that when cleaved 
releases renin.  Renin is synthesized, stored and secreted by specialized cells 
in the wall of the afferent arteriole of the kidney while prorenin is secreted 
constitutively mainly in the kidney but also to a much smaller extent by other 
organs like adrenal gland, eye, and reproductive organs 60. 
In line with some studies that point to a local tissue RAS production 61, 
the (pro)renin receptor ((P)RR) was discovered in 2002 by G. Nguyen 62. 
Renin and prorenin can both bind to (P)RR, the first has its activity increased 
and the latter gains enzymatic activity without removal of the pro-segment 
(conformational change without cleavage of the pro-segment).  
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The (P)RR is a 350 amino acid protein that is expressed in the brain, 
heart, liver, kidney, muscle, adrenal glands, pancreas, ovary, and placenta 62. 
In the kidney (P)RR expression was found in mesangial cells 62, podocytes 63 
in the proximal tubule and in  intercalated cells 64. At the cellular level (P)RR is 
mainly found in intracellular organelles but it can also be found in the plasma 
membrane like for instance in the intercalated cells 64,65. 
The (P)RR protein has 4 domains: a N-terminal signal peptide, an 
extracellular domain that allows renin and prorenin binding, a single 
transmembrane domain, and a short cytosolic domain 66 (figure 5). It contains 
also a furin cleavage site that undergoes cleavage in the trans- Golgi network 
by ADAM19 giving origin to a soluble form, s(P)RR, that is secreted into the 
extracellular space 67,68. The (P)RR transmembrane and cytoplasmic domain 
was found to be identical to the M8-9 protein, a potential accessory subunit of 
H+-ATPases and since then (P)RR is also named ATP6ap2 69.  
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1.3.1 (P)RR/ ATP6AP2 functions 
The (P)RR/ATP6ap2 has functions dependent and independent from 
Angiotensin I (ANG I) production. Regarding functions dependent on ANGI 
production, (P)RR/ATP6ap2 allows activation of prorenin and increase of 
renin`s catalytically activity62. Studies with low sodium diet and ANG II 
overproduction lead to a increase in (P)RR/ ATP6ap2 expression suggesting 
that it may be involved in salt and water regulation by the kidney 70,71.In a  
recent study with a conditional knockout for (P)RR/ATP6ap2 only in kidney 
epithelial cells, this role of the (P)RR/ATP6ap2 in salt and water homeostasis 
was investigated in detail. Knockout mice for (P)RR/ATP6ap2 had diluted 
urine, higher water intake as a consequence of reduced aquaporin 2 and 
arginine vasopressin levels in renal medulla72. However, this may rather be 
the consequence of loss of medullary tissue and hydronephrosis. In line, 
Trepiccione et al showed that renal expression of the (P)RR/ATP6ap2 was 
not necessary for normal activation of the RAS 73. 
Apart from the ANG I production when (P)RR/ATP6ap2 ligands bind 
they may activate mitogen-activated protein kinase (MAPK) signaling and 
extracellular signal regulated kinase (ERK1/2) 74. The activation of these 
kinases per se activates other signaling molecules like transforming growth 
factor–β1 (TGF-β1) 75, plasminogen–activated inhibitor 1 (PAI-1) 76, 
cyclooxygenase-2 (COX2) 77,78, interleukin-1  and tumor necrosis factor α 
(TNFα). The (P)RR/ATP6ap2 seems also to be involved in arginine 
vasopressin signaling, as it was demonstrated in a study performed in Madin-
Darby canine kidney C11 cells 79. In regard to ANG I independent functions 
but ligand dependent functions there are some controversies since most of 
the studies used renin and prorenin in supra-physiological concentrations (nM 
concentration instead of the physiological picomolar range), leading to the 
belief that there might be (an)other receptor(s) for these ligands. 80  
During development (P)RR/ATP6ap2 functions independently of its 
ligands, by serving as a physical adaptor between Fz/LPR6 (canonical 
elements of Wnt/ β–catenin signaling) and vacuolar H+-ATPase 81. It was 
reported that the (P)RR/ATP6ap2 is also involved in a non-canonical Wnt 
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signaling or planar cell polarity pathway (PCP) 82,83. In these two studies 
(P)RR/ATP6ap2 deletion affected H+-ATPase function suggesting the 
importance of the (P)RR/ATP6ap2 for H+-ATPase function.  
The (P)RR/ATP6ap2 was also shown to be important for kidney 
development via two different embryonic precursor cells: ureteric bud and cap 
mesenchymal cells 84,85. These studies demonstrate that the (P)RR/ATP6ap2 
is essential for nephron development and renal function postnatally. In 
another study, involving a inducible conditional knockout in the kidney 
epithelial cells, the (P)RR/ATP6ap2 was shown to be important for urine 
concentration 72. Knockout animals for (P)RR/ATP6ap2 displayed a lower 
urine osmolality, higher water intake, and higher urine volume compared with 
control mice. The authors suggested that this could be due to lower levels of 
AQP2 and arginine vasopressin-induced cAMP in the medulla. Furthermore, 
in a more recent study using the same animal model, (P)RR/ATP6ap2 
deletion resulted in a defect in the TAL, in PCs and ICs in the kidney 73. 
Similarly, in this recent study, knockout mice for (P)RR/ATP6ap2 showed 
polyuria and polydipsia. Furthermore, medullary Na+-K+-2Cl2 cotransporter 
(NKCC2) and AQP2 was reduced in the knockout animals. Interestingly, these 
mice also suffer from renal distal tubule acidosis due to reduce expression of 
H+-ATPase subunit B1. They further show that (P)RR/ATP6ap2 deletion leads 
to autophagy defects in intercalated cells. 
(P)RR/ATP6ap2 also has functions as a putative H+-ATPase subunit. 
These functions will be discussed in detail in section 1.5. 
1.4. H+-ATPase  
The H+-ATPase is multisubunit membrane-bound protein complex 
consisting of two main domains, a cytosolic domain, V1, and a membrane 
inserted domain, V0 (figure 6). The V1 catalyzes ATP binding and hydrolysis, 
while the V0 domain mediates proton translocation 86-88 . The V1 domain is 
composed of 8 different subunits (A,B,C,D,E,F,G,H) while V0 is composed of 
6 different subunits (a,d,e,c,c’,c’’). The A and B subunits of the V1 domain 
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facilitate ATP binding and hydrolysis, while the remaining subunits form the 
central and peripheral stalks connecting the V1 to the V0 domain.  
 
The central stalk transfers the energy generated from the ATP 
hydrolysis to the rotary ring on the V0 domain, while the peripheral stalk is 
essential for preventing the rotation of the V1 domain. Furthermore, the 
proteolytic ring in the V0 domain is involved in proton translocation 80,87,88. The 
presence of additional subunit isoforms and splice variants in mammals along 
with tissue specific expression differences adds to the already existing 
structural complexity. As an example, expression of a4, B1, and d2 H+-
ATPase subunits have been described to be enriched in the kidney 81,87-89.  
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1.4.1 H+-ATPase intracellular functions 
H+-ATPase can be present in intracellular organelles, like lysosomes, 
endosomes and secretory vesicles. In these organelles, H+-ATPase has a 
major function in acidification which allows processes like membrane 
trafficking, activation of ligand-receptor dissociation, protein processing or 
degradation and neurotransmitter uptake into secretory vesicles 82,83,88. The 
role of H+-ATPases in receptor-mediated endocytosis has been studied with 
the aid of pharmacological tools such as ionophores, weak bases and H+-
ATPase specific inhibitors (concanamycin and bafilomycin). In these studies, 
changes in endosomal pH resulted in non-dissociation of internalized ligand-
receptor complexes and blocking of the recycling endosomal pathway that 
delivers unoccupied receptor back to the plasma membrane 11,90,91. 
Furthermore, lysosomal enzymes require a low pH for their optimal activity 
and function in the degradation of internalized content. H+-ATPase ensures, 
maintains and stabilizes an acidic pH in lysosomes. H+-ATPase also 
generates pH gradients and positive membrane potential in secretory vesicles 
necessary for neurotransmitters, like glutamate and noradrenaline, to be 
taken up into secretory vesicles at the synapses 11,88. 
Besides H+-ATPase functions in membrane trafficking, H+-ATPase is 
also thought to be a intracellular or intraorganellar pH sensor 92. H+-ATPase 
was shown to be important for recruitment of the GTPase Arf6 and GDP/GTP 
exchange factor (GEF) ARNO (ADP-ribosylation factor nucleotide site opener) 
to endosome membranes. Recruitment of Arf6 and ARNO to their target 
membranes is important for endosome regulation. Inhibition of interactions 
between H+-ATPase–ARNO–Arf6 leads to endosome impairments namely in 
the transition between early and late endosomes 93. This study also 
suggested that H+-ATPases are not only important for intracellular 
acidification but also for signaling by helping recruiting other proteins. 
Furthermore, H+-ATPases also act as a cytohesin-2 signaling receptor, a 
protein also known to be a regulator of signaling in the endosomal machinery 
94-96. Cytohensin-2/Arf6 in collaboration with H+-ATPase are important for 
regulation of megalin/ cubilin receptor-mediated endocytosis in proximal 
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tubule cells in situ. The H+-ATPase a2 subunit was indicated as a potential 
endosomal pH sensor and binding site for the above mentioned signaling 
molecules 97,98. It is important to mention that H+-ATPase interactions with 
other signaling partners relevant for trafficking happen in a pH dependent 
manner.  
Recent studies, unraveled that H+-ATPases are a component of the 
mammalian target of rapamycin 1 complex (mTORC1) and signaling pathway 
99. mTOR complex 1 initiates growth signaling pathways upon stimulation by 
growth factors, changes in the concentration of specific amino acids, oxygen 
levels or energy  and stress levels.  Additionally, H+-ATPases were shown to 
be involved in sensing of lysosomal amino acid content which followed by 
interaction with Ragulator complex drives recruitment of mTOR complex 1 to 
the lysosome membrane and further activation 100,101. Therefore, according to 
these studies, H+-ATPases play an important role in amino acid sensing in 
lysosomes and mTOR complex 1 signaling. Interestingly, in a recent study 
using a drosophila model, it was discovered that H+-ATPase/mTOR signaling 
regulates megalin mediated apical endocytosis 102. In the same study but 
using a mouse model in which mTOR was pharmacologically inhibited, these 
animals displayed proteinuria and lower levels of megalin in kidney BBM. This 
paper suggested that mTOR reduction was a potential reason for tubular 
proteinuria via megalin 102. 
 
1.4.2 H+-ATPase plasma membrane functions 
Although H+-ATPases are mainly present in intracellular organelles, 
they can also be found in the plasma membrane of certain cells like 
osteoclasts, proximal tubule cells, intercalated cells in the kidney, clear cells in 
the epididymis, and tumor cells. H+-ATPases in plasma membranes mediate 
cell specific functions such as bone reabsorption, regulation of body pH 
homeostasis, sperm maturation and tumor cell invasiveness 86,88,90.  
Bone density is a balance between bone resorption by osteoclasts and 
bone formation by osteoblasts. Osteoclasts through H+-ATPases, secrete acid 
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and digestive enzymes into the extracellular space digesting bone matrix. H+-
ATPases function in these cells is illustrated by genetic defects in the a3 
subunit (ATP6V0a3), the responsible subunit for targeting H+-ATPases to the 
osteoclast ruffled membrane. Mutations in the a3 subunit result in 
osteopetrosis that is characterized by excessive bone formation 88,89,103. 
Sperm maturation and viability requires low extracellular pH, which is 
provided by clear cells from the epididymis. Clear cells express specific H+-
ATPase isoforms like E1 in their apical membranes therefore the H+-ATPase 
has been suggested as a good contraceptive drug target 88,91. 
Recent evidence links tumor invasiveness with the presence of H+-
ATPases in the cell membrane where it produces an acidic environment 
necessary for cathepsin function. Cathepsins are necessary for extracellular 
matrix degradation allowing tumors to become more invasive. This evidence 
is also supported by the overexpression of H+-ATPases in different cancer cell 
lines and tumor samples 88,98,104.  
 
1.4.3 H+-ATPase in the kidney 
In the kidney, H+-ATPases are located in the brush border membrane 
in the PT, the apical membrane of the thick ascending limb of the loop of 
Henle and in the plasma membrane of intercalated cells (IC). In the brush 
border membrane of the PT, H+-ATPases play an important role in proton 
secretion, which in turn is essential for bicarbonate reabsorption. In addition, 
H+-ATPases are important for absorption and processing of small proteins in 
the PT by promoting acidification of endocytic vesicles necessary for 
dissociation of ligands from internalized ligand-receptor complexes (receptor-
mediated endocytosis), maturation of endocytic vesicles, and activity of 
lysosomal enzymes 86. H+-ATPase brings protons from the cytoplasm to the 
intracellular organelle generating a positive potential that is neutralized mainly 
by Cl-/H+ antiporters (CLC-5 in the kidney). While endocytic uptake is 
regulated by megalin and cubulin in the PT case, the progression through the 
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endocytic machinery to the lysosome depends on vesicular acidification which 
in turn is H+-ATPase dependent 95. 
The plasma membrane localization of the H+-ATPase in IC is 
responsible for urine acidification which is essential for acid-base homeostasis 
87,105. Based on morphology and function, IC can be further subdivided into 
type-A intercalated cells (A-IC) and type–B intercalated cells (B-IC). A-IC 
secrete protons into the urine and transport bicarbonate to blood, and B-IC 
secrete bicarbonate into urine and protons into blood. Furthermore, A-IC are 
characterized by the presence of H+-ATPases at their apical pole and the Cl-
/HCO3- exchanger Ae1 (anion exchanger 1, band3 or Slc4a1) at the 
basolateral side. However, in B-IC the H+-ATPase is expressed at the 
basolateral side and a different Cl-/HCO3- exchanger, pendrin, is expressed at 
the apical side.  There is also a third type of IC, non-A non-B, that does not 
express Ae1 but expresses pendrin in the apical side and H+-ATPase in both 
basolateral and apical membranes 106. The function of this IC type is still 
unclear. 
The relevance of H+-ATPases for kidney function is reflected by the 
phenotype of animal models and by the kidney symptoms in human diseases 
with mutations in specific H+-ATPase subunits.  The H+-ATPase has kidney 
enriched subunits like a4, which is expressed in the plasma membrane of IC 
and the PT (also in intracellular organelles) and B1 that is expressed in IC. 
Knockout animal models for these specific subunits allow investigating H+-
ATPase function in the kidney 87,91,107. 
To illustrate H+-ATPase function in the PT, a recent study executed 
with knockout mice for the a4 subunit showed that these mice not only suffer 
from metabolic acidosis due to loss of this subunit from IC but also had PT 
dysfunction. a4 knockout mice presented defective endosomal trafficking, 
proteinuria, phosphaturia and accumulation of lysosomal content 95,108,109.  
Mutations in the B1 subunit of the H+-ATPase cause impairment in 
acid/base homeostasis leading to a pathological condition referred to as distal 
renal tubular acidosis (dRTA). The patients suffering from dRTA suffer from 
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lack of urine acidification, hypokalemia and hypercalciuria 110. A knockout 
mouse for the B1 subunit surprisingly had only a mild baseline defect 
characterized by a slightly alkaline urine and normal blood pH 111. As a 
potential explanation for such a phenotype, it was found that these mice had a 
compensatory overexpression of the B2 H+-ATPase subunit in IC 111-113. 
 
1.5. (P)RR and H+-ATPase 
The first biochemical interaction between (P)RR/ATP6ap2 and H+-ATPase 
was reported in 1998 when H+-ATPases were copurified together with another 
protein M8-9 of 9.2 kDa from the chromaffin cells of the adrenal medulla 69. 
This protein was subsequently named ATP6ap2 for H+-ATPase associated 
protein 2; however, soon it became clear that M8-9 is a truncated form of the 
(P)RR/ATP6ap2, corresponding to the transmembrane and cytoplasmatic 
domains. Recent studies have shown that (P)RR/ATP6ap2 colocalizes with 
H+-ATPases in the plasma membrane of  intercalated cells in the CD 64  and 
in the Z-disc and dyad of cardiomyocytes 114. Moreover, B1 subunit 
immunoprecipitation from mouse kidney lysate and further proteomic analysis 
identified (P)RR/ATP6ap2 as an interactor of H+-ATPases 115. 
A more direct evidence for the role of the (P)RR/ATP6ap2 in regulating H+-
ATPases comes from functional studies in a (P)RR/ATP6ap2 deletion 
background which demonstrates a distinct downregulation of H+-ATPase 
function 116-119. It is worthwhile to mention that (P)RR/ATP6ap2 knock-down in 
cardiomyocytes results in a phenotype similar to pharmacological inhibition of 
H+-ATPase, suggesting the importance of the (P)RR/ATP6ap2 for H+-ATPase 
function 116. Furthermore, in podocyte specific (P)RR/ATP6ap2 knock-out 
mice it was demonstrated that expression of the c subunit of the H+-ATPase 
V0 domain is downregulated 120 giving a hint for possible subunit specific 
interactions. Both animal models exhibit accumulation of autophagic vesicles 
suggesting lysosomal defects. Also, (P)RR/ATP6ap2 was shown to be an 
adaptor protein between H+-ATPase and frizzle in the Wnt signaling 81,117 . In 
another study using a drosophila model, lack of (P)RR/ATP6ap2 affected 
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lysosome acidification leading to accumulation of E-Cadherin, Notch and 
LAMP1. The authors also suggest that (P)RR/ATP6ap2 function as endosome 
regulator is independent of its function in Wnt signaling 117. Moreover, another 
study in drosophila demonstrates that (P)RR/ATP6ap2 knockdown in pupal 
wings has a similar phenotype as H+-ATPase subunits knockdown, leading to 
defective uptake of dextran (fluid phase endocytosis) and avidin (receptor-
mediated endocytosis). The same study could also show that (P)RR/ATP6ap2 
knockdown down-regulates expression of megalin 102.  In a more recent study 
using a inducible conditional knockout mice for (P)RR/ATP6ap2 in kidney 
epithelial cells, it was shown that (P)RR/ATP6ap2 deletion leads to urinary 
concentration defects and distal renal tubule acidosis 73. They could show that 
deletion of (P)RR/ATP6ap2 does not impair the RAS system and that the 
observed phenotype results from deficient H+-ATPase activity. They even 
went one step further by suggesting that (P)RR/ATP6ap2 should no longer be 
called (P)RR. 
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2. Animal models used in the thesis 
In the present study, distinct mouse models were used to answer the 
question whether (P)RR/ ATP6AP2 is important for kidney function. 
Chapter 1:  
We used models to induce chronic metabolic acidosis and chronic 
metabolic alkalosis. Metabolic acidosis in C57/Bl6 wildtype mice was induced 
with NH4Cl (0.28 M) while metabolic alkalosis was induced with NaHCO3 (0.28 
M) or KHCO3 (0.28 M) in the drinking water for 7 days. Furthermore wild type 
mice also received NaCl (0.28 M) in the drinking water during 7 days. Animals 
received an aldosterone analogue desoxycorticosterone acetate (DOCA) via 
subcutaneous injections at day 1 and 4 (2 mg/mouse). These treatments have 
been shown to induce metabolic acidosis or alkalosis in rodents and induce 
regulation of major transport proteins expressed in intercalated cells like H+-
ATPase 107,121,122. All diets except of DOCA were given in drinking water 
supplemented with 1% sucrose and maintained on a standard diet. The 
control group received only 1% sucrose in drinking water. 
Chapter 2:  
To bypass the lethal effects of early developmental loss of (P)RR we 
used an inducible (P)RR/Atp6ap2 knock-down rat model .These transgenic 
rats expressed a small hairpin RNA (shRNA) that specifically target the 
(P)RR/ATP6ap2 transcript in the whole body 123. To induce expression of 
shRNA against (P)RR/Atp6ap2, animals were treated with 0.5 g/l doxycycline 
in the drinking water for 8 days. We used as control littermates wildtype rats 
not expressing Atp6ap2 shRNA but also receiving doxycycline.  To overcome 
the problem of a full knock-down, we produced another animal model in-
house in which (P)RR is deleted in an inducible fashion only in the epithelial 
cells along the nephron. We generated this mice by crossing Pax8rtTA 124 
with mice flox(P)RR/ATP6AP2 (the Atp6ap2 gene is on the X chromosome) 
	 34 
118. Expression of Cre-recombinase was induced in male (P)RR 
flox/y,Pax8Cre+ and (P)RR +/+,Pax8Cre+ transgenic mice by administration of 
0.5 mg/ml of doxycycline in drinking water containing 2% of sucrose for 5 
days followed by 5 days induction with 0.25mg/ml doxycycline in 2% sucrose 
drinking water and 4 days  recovery without doxycycline. This caused a partial 
knock-out of the (P)RR/ATP6ap2, mostly in the proximal tubule but left 
residual expression in intercalated cells reducing overall morbidity in animals 
due to loss of function of medullary collecting ducts. 
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3. Aim of the thesis 
Given that the H+-ATPase is highly expressed in the kidney in the 
plasma membrane of PT, IC cells and intracellular organelles, and that 
(P)RR/ATP6ap2 is coexpressed at high levels in the kidney, it is likely that the 
(P)RR/ATP6ap2 and H+-ATPases are functionally coupled. Thus, in this 
thesis, we aimed at study (P)RR/ATP6ap2 functions in the kidney in particular 
in the PT cells. 
In the chapter 1, we studied the localization of (P)RR/ATP6ap2 protein 
along the murine nephron and its co-localization with plasma membrane 
associated H+-ATPases. Furthermore, we looked at co-regulation of 
(P)RR/ATP6ap2 and main kidney specific H+-ATPase subunits B1 and a4 on 
mRNA and protein level. Finally, we also tested whether acute application of 
prorenin could regulate native plasma membrane H+-ATPase activity in 
intercalated cells in freshly isolated and microperfused mouse collecting 
ducts. 
In the chapter 2, we investigated the (P)RR/ATP6AP2 function in the 
PT using two different animal models. A rat model with an inducible shRNA 
for Atp6ap2 and an inducible kidney epithelial cell-specific knockout mouse for 
(P)RR/ATP6ap2. To study in more detail the endocytic pathway we injected 
both animal models with fluid phase endocytosis marker (dextran-FITC, 10 
kDa) and receptor mediated endocytosis marker (human transferrin). We 
report that (P)RR/ATP6ap2 plays a role in cargo reabsorption and processing 
via receptor-mediated endocytosis, hence, contributing to kidney proximal 
tubule function.   
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4. Experimental part/ manuscripts 
Chapter 1: Colocalization of the (Pro)renin Receptor/Atp6ap2 with 
H+-ATPases in Mouse Kidney but Prorenin Does Not Acutely Regulate 
Intercalated Cell H+-ATPase Activity. 
Marta F.L. Figueiredo contributions: performed immunohistochemistry for 
figure 4 and figure 8.  
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ABSTRACT 
 
The (Pro)renin receptor (P)RR/Atp6ap2 is a cell surface protein capable of binding 
and non-proteolytically activate prorenin. Additionally, (P)RR is associated with H+-
ATPases and alternative functions in H+-ATPase regulation as well as in Wnt 
signalling have been reported. Kidneys express very high levels of H+-ATPases 
which are involved in multiple functions such as endocytosis, membrane protein 
recycling as well as urinary acidification, bicarbonate reabsorption, and salt 
absorption. Here, we wanted to localize the (P)RR/Atp6ap2 along the murine 
nephron, exmaine whether the (P)RR/Atp6ap2 is coregulated with other H+-ATPase 
subunits, and whether acute stimulation of the (P)RR/Atp6ap2 with prorenin regulates 
H+-ATPase activity in intercalated cells in freshly isolated collecting ducts. We 
localized (P)PR/Atp6ap2 along the murine nephron by qPCR and 
immunohistochemistry. (P)RR/Atp6ap2 mRNA was detected in all nephron segments 
with highest levels in the collecting system coinciding with H+-ATPases. Further 
experiments demonstrated expression at the brush border membrane of proximal 
tubules and in all types of intercalated cells colocalizing with H+-ATPases. In mice 
treated with NH4Cl, NaHCO3, KHCO3, NaCl, or the mineralocorticoid DOCA for 7 
days, (P)RR/Atp6ap2 and  H+-ATPase subunits were regulated but not co-regulated 
at protein and mRNA levels. Immunolocalization in kidneys from control, NH4Cl or 
NaHCO3 treated mice demonstrated always colocalization of PRR/Atp6ap2 with H+-
ATPase subunits at the brush border membrane of proximal tubules, the apical pole 
of type A intercalated cells, and at basolateral and/or apical membranes of non-type 
A intercalated cells. Microperfusion of isolated cortical collecting ducts and luminal 
application of prorenin did not acutely stimulate H+-ATPase activity. However, 
incubation of isolated collecting ducts with prorenin non-significantly increased 
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ERK1/2 phosphorylation. Our results suggest that the PRR/Atp6ap2 may form a 
complex with H+-ATPases in proximal tubule and intercalated cells but that prorenin 
has no acute effect on H+-ATPase activity in intercalated cells. 
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INTRODUCTION 
 
The (pro)renin receptor (P)RR is a protein spanning the membrane once and 
with a large extracellular domain. The extracellular domain can be cleaved to yield a 
soluble, shorter fragment of approximately 28 kDa [1,2,3]. The (P)RR was initially 
identified as a receptor for renin and prorenin, inducing non-proteolytical activation of 
prorenin and thus allowing local production of angiotensin I from angiotensinogen by 
both renin and prorenin. In addition, binding of prorenin and renin may activate an 
angiotensin-independent intracellular signaling cascade leading to enhanced ERK1/2 
phosphorylation [4].  
 
(P)RR is identical to ATP6AP2, a protein that associates and co-
immunoprecipitates with vacuolar-type H+-ATPases (V-ATPases) [5]. H+-ATPases 
are membrane-associated multi-protein complexes mediating the transport of protons 
by hydrolyzing ATP [6,7]. In the kidney, H+-ATPases are localized at the plasma 
membrane of most epithelial cells lining the nephron and mediate proton extrusion 
into urine or blood [8]. Moreover, H+-ATPases are found in many intracellular 
organelles such as endosomes and lysosomes and play there a critical role in 
endocytosis, e.g. receptor-mediated endocytosis in the proximal tubule [7,9]. The 
activity of plasma membrane-associated H+-ATPases is regulated by various 
hormones and factors including angiotensin II, aldosterone, acidosis or alkalosis [7]. 
Some of these effects are mediated by intracellular signaling cascades involving 
cAMP/PKA, PKC, ERK1/2 or AMPK [10,11,12,13,14]. Activation of these signaling 
pathways can result in enhanced trafficking and localization of H+-ATPases at the 
plasma membrane associated with increased activity. Disruption of signaling or the 
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actin cytoskeleton-dependent trafficking reduces plasma membrane H+-ATPase 
localization and stimulation [15,16,17,18,19,20,21].  
In various model organisms such as Drosophila or Xenopus laevis larvae, the 
(P)RR/Atp6ap2 is critical for fundamental cellular processes such as endocytic 
retrieval of proteins and Wnt signaling [22,23,24]. Whether these functions of the 
(P)RR/Atp6ap2 are related to its possible role as accessory subunit of the H+-ATPase 
or due to other functions has not been fully elucidated. However, endocytosis as well 
as Wnt signaling (e.g. the recycling of Wnt receptors) are sensitive to the disruption 
of other bona fide H+-ATPase subunits and H+-ATPase inhibitors providing a strong 
argument for a role of the (P)RR/Atp6ap2 in H+-ATPase trafficking, regulation, or 
function [22,24]. However, limited information is available  about the localization of 
the (P)RR/Atp6ap2 in kidney, an organ with very intense expression of H+-ATPases, 
and whether H+-ATPase activity itself can be affected by acute application of 
prorenin.  
 
The main questions addressed in this manuscript are 1) the localization of 
(P)RR/Atp6ap2 protein along the murine nephron and its colocalization with plasma 
membrane associated H+-ATPases, 2) the coregulation of (P)RR/Atp6ap2 and two 
major H+-ATPase subunits on mRNA and protein level, and 3) to test whether acute 
application of prorenin could regulate native plasma membrane H+-ATPase in 
intercalated cells in freshly isolated murine collecting ducts. 
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MATERIALS AND METHODS 
Animals  
Experiments were performed in 8-12 weeks old male C57BL/6 (body weight 
25-30 g) mice. All animal experiments were conducted according to Swiss laws for 
the welfare of animals and were approved by local authorities (Swiss Veterinary 
Authority of the Kanton Zurich, permission no 03/2011). The animals had free access 
to food and tap water. Where indicated NaCl (0.28 M), NaHCO3 (0.28 M), KHCO3 
(0.28 M), or NH4Cl (0.28 M) were added to the drinking water for 7 days. Animals 
receiving the aldosterone analogue desoxycorticosterone acetate (DOCA) received 
subcutaneous injections at day 1 and 4 (2 mg/mouse). These treatments have been 
shown to induce metabolic acidosis or alkalosis in rodents and induce regulation of 
major transport proteins expressed in intercalated cells [25]. Each group consisted of 
at least 5 animals and was compared to the time-, age- and gender-matched 
corresponding control groups. All diets except of DOCA were given in drinking water 
supplemented with 1% sucrose and maintained on a standard diet. The control group 
received only 1% sucrose in drinking water. 
For some experiments, mice were used expressing eGFP under the control of 
the Atp6v1b1 (B1) H+-ATPase subunit promoter inducing high levels of eGFP 
expression in intercalated cells along the collecting duct system (B1-eGFP mice) [26]. 
B1-eGFP mice were kindly provided by Dr. Lance Miller and Dr. Raoul Nelson, 
University of Utah, Salt Lake City.. 
 
Isolation of mouse nephron segments and mRNA extraction 
 Defined segments of mouse nephrons were isolated from the kidneys of 
untreated male C57BL/6 mice or B1-eGFP, 10 – 12 weeks old using hand-dissection 
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under a stereo microscope illuminated with normal light or fluorescent light (Leica 
M165FC). 
mRNA extraction of organs and hand-dissected isolated nephron segments with 
subsequent quantitative real time RT-PCR was performed as described previously 
[27]. Enrichment of the hand-dissected nephron segment preparation was ensured, 
by testing each sample for the most dominantly expressed segment specific mRNA 
transcripts (Podoplanin, NaPi-IIa, NKCC2, NCC, AQP2, and Pendrin). 
 
RNA extraction from kidney and semi-quantitative RT-qPCR analysis  
To determine (P)RR/ATP6AP2, ATP6V1B1, ATP6V0A4, and HPRT relative 
mRNA abundance in dissected tissues, total RNA was extracted from dissected 
kidney cortex and medulla using an RNeasy kit (Qiagen, Basel, Switzerland). RNA 
was bound to columns and treated with DNase for 15 min at room temperature to 
reduce genomic DNA contamination. Quantity and purity of total eluted RNA was 
assessed by spectrometry. To generate complementary DNA (cDNA), total RNA was 
reverse transcribed (RT reaction) by Taqman Reverse Transcription Kit (Applied 
Biosystems, USA). The thermal cycle conditions used were 25°C (10 min), 48°C (30 
min) and 95° (5 min). Primers and probes were designed using Primer Express 
(Applied Biosystems, USA) and purchased from Microsynth, Switzerland 
(Supplementary Table S1). The specificity of the primers was tested using adult 
mouse kidney cDNA by conventional PCR. Each pair of primers resulted only in a 
single band of the expected size (data not shown). Probes were labelled with the 
reporter dye FAM at the 5ʹ end and the quencher dye TAMRA at the 3ʹ end. RT-PCR 
reactions were performed using Taqman Universal PCR Master Mix (Applied 
Biosystems, USA)  17 µl reactions were prepared using 3 µl of cDNA-template. 
Reactions were run in 96-well Optical reaction plates and caps (Applied Biosystems, 
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USA). Thermal cycles were set at 50°C (2 min) 95°C (10 min) and then 40 cycles at 
95°C (15 sec) and 60°C (1 min). Each reaction was made in triplicates and the 
average taken. Samples without enzyme in the RT reaction were used as negative 
controls to exclude contamination with genomic DNA. Only results with less than 1 
cycle difference were taken into consideration. Cross point threshold (Ct  value) was 
taken as the earliest cycle number in the PCR amplification, when fluorescence rises 
significantly above the background fluorescence.  
The expression of candidate genes was normalized to the reference gene, HPRT 
giving comparable results and analyzed by the delta delta Ct method. 
  
MDCK cells and cell culture 
MDCK cells (C11 clone, kindly provided by Dr. H. Oberleithner, University of 
Münster, Germany) [28] were cultured at 37°C and 5 % CO2 in DMEM (no. E15-810, 
GE Healthare, Glattbrugg, Switzerland) supplemented with 10 % heat-inactivated 
fetal bovine serum (FBS, Sigma-Aldrich, Buchs, Switzerland), 2 mM L-glutamine, and 
1 % non-essential amino acids (no. M11-003, GE Healthcare). After cells had 
reached 80-90 % confluency, they were starved for 24 hrs and thereafter treated with 
the AT1R blocker losartan (10 µM, Sigma-Aldrich, Buchs Switzerland) and the AT2R 
blocker PD123319 (10 µM, Sigma-Aldrich, Buchs, Switzerland) for 30 min at 37°C 
followed by human prorenin (1 and 20 nM, a kind gift of Dr. Walter Fischli, Actelion, 
Allschwil, Switzerland) and angiotensin  II (10 nM, Sigma-Aldrich, Buchs Switzerland) 
stimulation for 10 min.  
 
Membrane preparation from kidney and western blot analysis 
For total membrane preparations, kidneys were dissected into cortex and 
medulla. Samples were homogenized in an ice-cold K-HEPES buffer (200 mM 
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mannitol, 80 mM HEPES, 41 mM KOH, pH 7.5) containing a protease inhibitor mix 
(Complete Mini, Roche Diagnostics, Germany) at a final concentration of 1 tablet in a 
volume of 10 ml solution. Samples were centrifuged at 2000 rpm for 20 min at 4°C. 
Subsequently, the supernatant was transferred to a new tube and centrifuged at 
41’000 rpm for 1 h at 4°C. The resultant pellet was resuspended in K-HEPES buffer 
containing protease inhibitors.  
 
MDCK cells were lysed with ice-cold Radio-Immunoprecipitation Assay (RIPA) 
buffer (150 mM NaCl, 50 mM Tris, pH 7.4, 1% NP-40, 0.5 % Na-Deoxycholate, 2 mM 
Phenylmethylsulfonylfluoride) supplemented with a protease inhibitor mix  (Complete 
Mini, Roche Diagnostics, Germany, at a final concentration of 1 tablet in a volume of 
10 ml solution) and incubated for 30 min on ice. Cellular debris was pelleted by 
centrifugation at 2500 g for 10 min at 4 °C. 
 
After measurement of the total protein concentration (Bio-Rad Dc protein 
Assay; Bio-Rad, Hercules, CA, USA), 10 µg of crude membrane proteins from cortex 
or medulla or 20 µg  of MDCK extracts were solubilised in Laemmli buffer, and SDS-
PAGE was performed on 10% polyacrylamide gels.  
For immunoblotting, proteins were transferred electrophoretically to 
polyvinylidene difluoride membranes (Immobilon-P; Millipore, Bedford, MA, USA). 
After blocking with 5% milk powder in Tris-buffered saline/0.1% Tween-20 for 60 min; 
the blots were incubated with the respective primary antibodies: goat anti mouse 
(P)RR 1:1000, Novus Biologicals, USA (NB100-1318), rabbit anti mouse ATP6V1B1 
1:5000 [29], rabbit anti-human ATP6V0A4 1:5000 [30], rabbit anti-pERK1/2 1:1000 
(Cell Signaling, 9101, Danvers, MA, USA), rabbit anti-total ERK1/2 1:1000 (Cell 
Signaling, 9102, Danvers, MA, USA , and mouse monoclonal anti-β-actin antibody 
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(42 kDa; Sigma, St. Louis, MO, USA) 1:5000, diluted in 1% milk/TBS-T) either for 2 h 
at room temperature or overnight at 4°C. After washing, the membranes were 
incubated for 1 h at room temperature with the secondary antibodies: donkey anti-
goat, goat anti-rabbit and goat anti-mouse IgG-conjugated with alkaline phosphatase 
1:5000 (Promega, WI, USA) and sheep anti-mouse IgG-conjugated with horseradish 
peroxidase (Amersham Life Sciences, 1:10000). Antibody binding was detected with 
enhanced chemiluminescence ECL kit (Amersham Pharmacia Biotech) or the CDP-
Star Western chemiluminescence Kit (Roche Diagnostics, Mannheim, Germany) 
using the DIANA III-chemiluminescence detection system (Raytest; Straubenhardt, 
Germany). All images were analyzed using appropriate software (Advanced Image 
Data Analyzer, Raytest, Straubenhardt, Germany) to calculate the protein of 
interest/β-actin ratio. 
 
Immunohistochemistry 
Mice were anesthetized with Ketamine/Xylazine and perfused through the left 
ventricle with phosphate-buffered saline (PBS) followed by paraformaldehyde-lysine-
periodate (PLP) fixative [31]. Kidneys were removed and fixed overnight at 4°C by 
immersion in PLP. Kidneys were washed 3 times with PBS and 5 µm cryosections 
were cut after cryoprotection with 2.3 M sucrose in PBS for at least 12 h. 
Immunostaining was carried out as described previously [32,33,34]. Briefly, sections 
were incubated with 10 mM TRIS (Trizma Base, Sigma, pH 10 at 100 °C for 20 min 
in a microwave, washed 3 times with PBS and incubated with 5 % (v/v) donkey 
serum in PBS for 15 min prior to the primary antibody. The primary antibodies (goat 
anti-(P)RR (Novus Biologicals, USA) 1:100), rabbit anti-ATP6V0A4 (a4) serum 
1:1000 [29,30], rabbit polyclonal anti ATP6V1B1 (B1) 1:150 [29], guinea-pig anti-
pendrin 1:1000 [35], guinea-pig anti-AE1 1:500 [36], and rabbit-anti-AQP2 (kindly 
The prorenin receptor/Atp6ap2 and renal H+-ATPases 
 
 
provided by J. Loffing, Zurich)[37] 1:1000 were diluted in PBS and applied either for 
75 min at room temperature or overnight at 4°C. Sections were then washed twice for 
5 min with high NaCl PBS (PBS + 18 g NaCl/l), once with PBS, and incubated with 
dilutions of the secondary antibodies (donkey anti-rabbit 586 (1:1000), donkey anti-
goat 488 (1:1000), donkey anti-guinea-pig Dylight 649 (Jackson ImmunoResearch 
Lab Inc) (1:1000) mixed with DAPI (Molecular Probes, Oregon, USA) 1:1000 for 1 h 
at room temperature. Sections were again washed twice with high NaCl PBS and 
once with PBS before mounting with glycergel mounting medium (Dako, USA). 
Sections were viewed with a Leica DM5500B epifluorescence microscope and for 
images comparing localization and intensity of stainings pictures were taken on the 
same day and with identical settings for gain, intensity, and fluorescence filters. 
Images were processed (overlays) using Adobe Photoshop. 
 
In vitro microperfusion experiments 
Mice were anesthetized with Xylazin/Ketamin i.p., both kidneys were cooled in 
situ with control bath solution containing in mM (138 NaCl, 1.5 CaCl2 1.2 MgSO4, 2 
K2HPO4, 10 HEPES, 5.5 glucose, 5 alanine, pH 7.4) for 1 min and then removed and 
cut into thin coronal slices for tubule dissection. Cortical collecting ducts (CCDs) were 
dissected under a stereo microscope from the cortex at 10°C in the control solution. 
 
Intracellular pH measurement 
The isolated  cortical collecting ducts were transferred into the bath chamber 
on the stage of an inverted microscope (IX81, Olympus, Japan) in the control solution 
and then mounted on concentric pipettes and perfused ex vivo with Na+-free, 
ammonium-free solution where N-methyl-D-Glutamine+ (NMDG+) replaced Na+. The 
average tubule length exposed to bath fluid was limited to 300 – 350 µm in order to 
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prevent motion of the tubule. CCDs were loaded with 5 µM of the fluorescent probe 
BCECF-AM (2’,7’-bis(2-carboxyl)-5-(and-6)-carboxyfluorescein acetoxymethyl ester, 
Invitrogen, Switzerland) for ~20 min at 37°C in the control bath solution. The loading 
solution was then washed out by initiation of bath flow and the tubule was 
equilibrated with dye-free control bath solution for 5 min. Luminal incubation with 
prorenin (20 pM and 1 nM) was initiated during the BCECF loading and prorenin was 
presented throughout the incubation period and experiment (approx.40 min). Bath 
solution was delivered at a rate of 20 ml/min and warmed to 37°C by water jacket 
immediately upstream to the chamber. After temperature equilibration in control 
solution, tubules were first transiently acidified by peritubular Na+ removal (Na-free, 
ammonium-free solution) (10 min duration), where sodium was replaced by NMDG+ 
to avoid exit of NH4+ by basolateral Na+-coupled transport. This maneuver was done 
in the luminal absence of Na+. During the fluorescence recording, perfusion solution 
was delivered to the perfusion pipette via a chamber under an inert gas (N2) pressure 
(around 1 bar) connected through a manual 6-way valve. With this system, opening 
of the valve instantaneously activates flow of solutions. The majority of the fluid 
delivery to the pipette exits the rear of the pipette system through a drain port at 4 
ml/min. This method results in a smooth and complete exchange of the luminal or the 
peritubular solution in less than 3 to 4 s [38].  
After the fluorescence signal stabilization, luminal fluid was instantly (at the 
rate of 4 ml/min in the draining) replaced by a Na+-free solution containing 20 mM 
NH4Cl (and 118 mM NMDG-Cl) that elicited a rapid intracellular alkalinization, 
followed by a sharp acidification. The rate of intracellular alkalinization has been 
associated with the entry of NH3 whereas the subsequent phase of intracellular 
acidification in the continous presence of extracellular NH4Cl reflects mostly NH4+ 
entry [39]. Intracellular dye was excited alternatively every 2 seconds at 434 and 494 
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nm with a MT fluorescence light source (150W Xenon/Mercury mixed gas burner) 
including a light guide and coupling to a disk scan Unit (Olympus, Japan). Emitted 
light was collected through a dichroïc mirror, passed through a 530 nm filter and 
focused onto a EM-CCD camera (Hamamatsu, Japan) connected to a computer. The 
measured light intensities were digitized with the CellM&CellR Imaging hardware 
system (Olympus, Japan) for further analysis. Intracellular dye was calibrated at the 
end of each experiment using the high [K+]-nigericin technique. Tubules were 
perfused and bathed with a HEPES-buffered, 95-mM K+-solution containing 10 µM of 
the K+/ H+-exchanger nigericin. Four different calibration solutions, titrated to pH 6.3, 
6.9 ,7.5, or 7.8 were used. 
 
Statistical analysis 
Data are provided as means ± SEM; n represents the number of independent 
experiments. All data were tested for significance using Student's unpaired two-tailed 
t-test, or ANOVA, where applicable. The level of statistical significance was set at * p 
< 0.05, ** p < 0.01 and *** p < 0.001.  
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RESULTS 
 
Localization of the (pro)renin receptor/Atp6ap2 in mouse kidney 
The distribution of (pro)renin receptor/Atp6ap2 mRNA was examined in mouse 
kidney using hand-dissected nephron segments by semi-quantitative RT-qPCR. 
(P)RR/Atp6ap2 mRNA was detected in the glomerulus and all other segments, with 
highest levels in the connecting tubule/cortical collecting duct (CNT/CCD) and outer 
medullary collecting duct (OMCD) (Figure 1). The high mRNA abundance of 
(P)RR/Atp6ap2 in CNT/CCD and OMCD was paralleled by high mRNA levels of the 
B1 (Atp6v1b1) H+-ATPase subunit which is selectively enriched in intercalated cells 
[40,41]. The enrichment of nephron segments was ascertained by RT-qPCR for 
segment specific markers (Podoplanin for the glomerulum, NaPi-.IIa for the S1 /S2 , 
S3 segments of the proximal tubule and DCT, NKCC2 for the TAL, NCC for the DCT, 
AQP2 for the collecting duct system, and pendrin for the CNT/CCD). Patterns of 
expression are in good agreement with previous transcript analyses along the mouse 
nephron [42].  
  
Immunohistochemistry detected weak (P)RR/Atp6ap2 related staining in the 
glomerulus as described before [43,44]. However, clear signals were detected in the 
proximal tubule at the brush border membrane and in cells in the collecting duct 
system (Figure 2 A,B). Costaining of (P)RR/Atp6ap2 with the a4 (Atp6v0a4) H+-
ATPase subunit, which is expressed along the entire nephron [32,45,46], showed 
strong overlay at the apical side of proximal tubular cells (Figure 2 D-F). In the 
collecting duct, costaining with the principal cell specific marker AQP2 demonstrated 
that the (P)RR/Atp6ap2 was expressed in intercalated cells (Figure 2 C). Further 
studies demonstrated that the (P)RR/Atp6ap2 colocalized in intercalated cells with 
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the a4 (Atp6v0a4) H+-ATPase subunit that forms part of the plasma membrane H+-
ATPase (Figure 3) [9,47]. 
H+-ATPases in intercalated cells can be associated with the luminal 
membrane in type A intercalated cells and with either the basolateral and/or luminal 
membrane in non-type A intercalated cells [7,8,32,48,49]. Type A intercalated cells 
were identified by the presence of AE1 specifically expressed at the basolateral 
membrane of these cells. In AE1 positive cells, (P)RR/Atp6ap2 staining was always 
detected at the luminal side of cells (Fig. 4A, B). In cells expressing pendrin, a marker 
of non-type A intercalated cells which is localized at the luminal membrane, 
(P)RR/Atp6ap2 staining was observed either at the basolateral membrane and/or 
colocalizing with pendrin at the luminal pole (Fig. 4C, D).  
 Thus, the (P)RR colocalizes with H+-ATPases at the plasma membrane in 
various nephron segments and can be found both at the apical side of cells in the 
proximal tubule and in type A and non-type A intercalated cells as well as at the 
basolateral side of some non-type A intercalated cells as previously described for 
other H+-ATPase subunits [32,40,41,46,48,49]. 
 
Regulation of (P)RR/Atp6ap2 mRNA and protein abundance in kidney by acid-
base status and electrolyte intake  
Mice were treated with different diets to alter activity of the different subtypes 
of intercalated cells and renal handling of bicarbonate and protons, conditions that 
have been associated with altered activity, expression, and/or localization of H+-
ATPases along the nephron [32,48]. 
Semi-quantitative qPCR was used to assess the relative abundance of 
mRNAs encoding (P)RR, B1 and a4 subunits of the vacuolar H+-ATPase in dissected 
cortex and medulla from control mice and animals that had received NaCl, NaHCO3, 
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KHCO3, NH4Cl, or the mineralocorticoid DOCA for 7 days (n = 5 per group). The 
abundance of (P)RR/Atp6ap2 mRNA was significantly increased in kidney cortex 
from NaHCO3 treated mice and reduced with NH4Cl treatment (Fig. 5). Atp6v1b1 
mRNA was higher in cortex with NaHCO3 treatment and Atp6v0a4 mRNA increased 
with NH4Cl supplementation (Fig. 5). In kidney medulla, (P)RR/Atp6ap2 mRNA was 
not altered by any of the diets, whereas Atp6v1b1 mRNA decreased with NaCl, 
NH4Cl, and DOCA treatments. Similarly, Atp6v0a4 mRNA expression in medulla was 
reduced with NaHCO3 or DOCA treatments. Thus, these data provided no evidence 
for coordinated regulation of mRNA expression of these three genes. 
 
 Next we assessed protein abundance of (P)RR/Atp6ap2, and the B1 and a4 
H+-ATPase subunits separately in kidney cortex and medulla. In cortex, NaHCO3 
treatment resulted in a significant increase in the protein abundance of (P)RR protein 
whereas all other treatments had no influence (Fig. 6). The expression of the B1 
(Atp6v1b1) subunit was reduced by NaCl intake and increased by alkali treatment 
such as NaHCO3 or KHCO3, whereas NaHCO3, KHCO3, and NH4Cl increased the a4 
(Atp6v0a4) subunit. In contrast, DOCA reduced a4 protein expression. In medulla, 
(P)RR/Atp6ap2 abundance was not regulated, whereas B1 abundance increased 
with KHCO3 and decreased with NaHCO3 treatment. Moreover, a4 expression 
decreased with NaHCO3, KHCO3, NH4Cl and DOCA treatments (Fig. 7). Similar to 
the mRNA data, these experiments did not indicate coordinated regulation of protein 
abundance of H+-ATPase subunits and (P)RR/Atp6ap2. 
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Trafficking of H+-ATPase and (P)RR/Atp6ap2 in response to alkali and acid 
loading 
 Loading of rodents with either alkali/bicarbonate or acid (NH4Cl) provokes 
increased trafficking of H+-ATPase subunits to the basolateral membrane of non-type 
A intercalated cells or luminal membrane of type A intercalated cells, respectively 
[32,48,49]. We performed immunohistochemistry for the a4 H+-ATPase subunit 
together with the (P)RR/ Atp6ap2 and AE1 as a marker of type A intercalated cells on 
kidneys from control mice and mice receiving NaHCO3 or NH4Cl for 7 days (Figure 
8).  In the proximal tubule, the signals for (P)RR/Atp6ap2 (green) and a4 H+-ATPase 
(red) showed a high degree of colocalization as indicated by the strong yellow color 
(Figure 8 B, E, H). Similarly, in intercalated cells, (P)RR and a4 H+-ATPase strongly 
colocalized at the luminal and/or basolateral side (Figure 8 A, C, D, F, G, I). In AE1 
positive intercalated cells, yellow staining was confined mostly to the luminal 
membrane, whereas in intercalated cells negative for AE1, yellow staining was 
detected at the luminal and/or basolateral side. Neither NaHCO3 nor NH4Cl treatment 
did alter the apparent costaining, at least at the level of light microscopy. 
 
Acute exposure of ex vivo microperfused collecting ducts to prorenin does not 
stimulate H+-ATPase activity and ERK1/2 phosphorylation 
The (P)RR/Atp6ap2 has been identified because of its ability to bind prorenin 
and experiments in MDCK cells demonstrated increased ERK1/2 phosphorylation 
and stimulated H+-ATPase activity when incubated with prorenin [50,51] . Thus, we 
tested in freshly isolated and microperfused mouse cortical collecting ducts whether 
luminal application of prorenin could stimulate H+-ATPase activity also in ex vivo 
preparations (Fig. 9). However, luminal microperfusion with two different 
concentrations of prorenin (20 pM and 1 nM) for 15 minutes did not alter H+-ATPase 
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activity measured as pHi recovery rates after intracellular acidification with a NH4Cl 
prepulse (20 mM) as described previously [13,20,21,29]. Next, we incubated hand-
dissected connecting tubules and cortical collecting ducts with prorenin (1 and 20 
nM) for 10 min at 37 °C in vitro. For these experiments, we used mice expressing 
eGFP in intercalated cells [26] to facilitate isolation of large enough quantities of 
these nephron segments for experiments. In three independent preparations, no 
difference in pERK1/2 abundance could be detected (Figure 10 A, B), however, 20 
nM prorenin caused a strong trend towards increased ERK1/2 phosphorylation (p = 
0.08). We performed parallel experiments in MDCK cells incubated for 10 minutes 
with prorenin (20 nM) or angiotensin II (10 nM) in the absence or presence of the AT1 
and AT2 receptor blockers losartan (10 µM) and PD123310 (10 µM) (Figure 10). In 
the combined presence of losartan and PD123310 a non-significant tendency to 
more pERK1/2 abundance (p = 0.2) was detected in MDCK cells incubated with 
prorenin (Figure 10 C, D). 
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DISCUSSION 
 
Our study provides new insights into the localization of the prorenin 
receptor/Atp6ap2 and its regulation in mouse kidney by confirming and expanding  
previous observations reporting the expression and localization of the (P)RR/Atp6ap2 
in the vasculature and podocytes of the glomerulus [4,43,44,52], in proximal tubule 
[52,53], and in the collecting duct [52] and intercalated cells  [50,54,55,56]. 
Here, we present the detailed expression and localization of the (P)RR along 
the entire nephron. Semi-quantitative qPCR showed abundant expression of 
(P)RR/Atp6ap2 mRNA in hand-dissected mouse nephron segments spreading from 
glomerulus to the distal segments including the collecting duct. Of note, the highest 
mRNA levels were found in the collecting duct system coinciding with the localization 
of intercalated cells. Previous experiments using in-situ hybridization in rat kidney 
had detected signals in proximal tubule and thick ascending limb of the loop of Henle 
(TAL) but with much weaker intensity than in the collecting duct supporting our 
observations [50]. Immunohistochemistry shows (P)RR/Atp6ap2 localization at the 
luminal membrane of proximal tubules and in all subtypes of intercalated cells. Weak 
immunohistochemical signals for (P)RR/Atp6ap2 were also detected in TAL and 
distal convoluted tubule (DCT) and were very weak or absent from segment-specific 
cells (principal cells) in the collecting duct system. In intercalated cells, localization of 
the (P)RR/Atp6ap2 differed between specific cell subtypes. In type A intercalated 
cells, identified by positive basolateral localization of AE1 [57], (P)RR/Atp6ap2 
staining was detected only at the luminal pole consistent with the luminal localization 
of H+-ATPases in these cells [7,49]. Consistently, Advani and colleagues had 
reported the localization of immunogold-labeled (P)RR/Atp6ap2 at the luminal 
membrane of rat type A intercalated cells with electron microscopy [50]. In contrast, 
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intercalated cells expressing pendrin (type B and non-A/non-B intercalated cells) 
[58,59] showed luminal, basolateral or combined (P)RR/Atp6ap2 staining as reported 
previously also for other H+-ATPase subunits [32,46,48,49]. Accordingly, 
(P)RR/Atp6ap2 staining colocalized at the level of light microscopy with the 
a4/Atp6v0a4 H+-ATPase subunit at the brush border membranes of proximal tubule 
cells and in all subtypes of intercalated cells. Thus, the (P)RR/Atp6ap2 is apparently 
localized to kidney cells where plasma membrane-associated H+-ATPases are also 
expressed such as in the proximal tubule and intercalated cells.  
Next we examined whether mRNA and protein abundance of the 
(P)RR/Atp6ap2 paralleled mRNA and protein expression levels of two H+-ATPase 
subunits, a4/Atp6v0a4 and B1/Atp6v1b1, in membrane preparations from kidney 
cortex and kidney medulla from mice subjected to different treatments known to 
affect acid-base status and H+-ATPase regulation [25,32,35,48,60,61]. Changes in 
acid-base and electrolyte balance caused changes in mRNA and protein expression 
of all three molecules but did not show an uniform and obvious pattern of 
coregulation. At the level of the kidney cortex this may not be surprising since the 
preparation contains a mixture of proximal tubules, connecting tubules, and cortical 
collecting ducts which may have differential patterns of regulation. The medullary 
preparations (from outer and inner medulla) are more homogenous and thus 
representative for medullary collecting ducts even though containing also fractions 
from the late proximal tubule and medullary TALs [62]. Nevertheless, no consistent 
coregulation of the H+-ATPase subunits and the (P)RR/atp6ap2 was observed. Along 
the same line, B1 and a4 subunit isoforms showed varying responses which may 
reflect different expression patterns. Part of the changes in H+-ATPase subunit 
isoform expression and (PRR/Atp6ap2 may also be due to remodeling of the 
collecting duct that during chonic changes in electrolyte and acid-base status can 
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affect the relative abundance of principal versus intercalated cells as well as the 
relative frequency of the different intercalated cell subtypes [25,63]. 
 
Regulation of the (P)RR/Atp6ap2 has been shown in rodent models subjected 
to low or high salt intake [52,64]. Similar to our results no effect of high salt intake on 
(P)RR/Atp6ap2 mRNA was detected [52] whereas low salt diet increased 
(P)RR/Atp6ap2 mRNA [64,65]. In contrast, on protein level high salt diet was 
associated with increased full length (P)RR/Atp6ap2 protein expression in cortex and 
medulla which was attributed to changes in glomerular and proximal tubular 
abundance [52]. But also low salt intake caused higher expression of (P)RR/Atp6ap2 
protein at the level of the total kidney [64,65,66]. The functional relevance of the 
seemingly same response of the (P)RR/Atp6ap2 to both high and low salt intake are 
not known to date. 
 
Regulation of H+-ATPase activity occurs on several levels involving assembly 
and disassembly of V0 and V1 sectors, trafficking of pumps into and from the 
membrane, and phosphorylation of subunits [6,7]. Changes in acid-base status or 
electrolyte homeostasis as well as aldosterone or its analogue DOCA have been 
shown to induce marked redistribution of H+-ATPases in intercalated cells with more 
pronounced membrane association at the luminal membrane in type A intercalated 
cells upon NH4Cl or DOCA treatment [13,20,32,48,67]. Likewise, supplementation 
with bicarbonate leads to a strong staining of basolateral and/or luminal membranes 
in type B and non-A/non-B intercalated cells [32,48,67]. Thus, we tested whether the 
(P)RR/Atp6ap2 would colocalize with the a4/Atp6v0a4 H+-ATPase subunit that has 
been previously shown to participate in the trafficking of H+-ATPases to the different 
membrane domains in type A and non-type A intercalated cells [32]. Detailed 
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analysis of intercalated cells in the connecting tubule and medullary collecting duct 
showed that (P)RR/Atp6ap2 and the a4/Atp6v0a4 H+-ATPase subunit showed a high 
degree of colocalization both in intercalated cells stained for AE1 (type A intercalated 
cells) and intercalated cells negative for AE1 (non-type A intercalated cells). In the 
latter cell population, (P)RR/Atp6ap2 and a4/Atp6v0a4 were detected at the 
basolateral and luminal membrane as expected and consistent with the detection of 
(P)RR/Atp6ap2 in pendrin positive cells (Figure 4C,D). Also in the proximal tubule, 
(P)RR/Atp6ap2 and a4/Atp6v0a4 strongly colocalized at the brush border membrane 
under all treatments. Thus, the (P)RR/Atp6ap2 appears to colocalize with H+-
ATPases under different conditions inducing a subcellular redistribution of pumps.  
 
 In a last set of experiments we addressed the question whether prorenin 
would acutely affect basal H+-ATPase function in type A intercalated cells. Isolated 
cortical collecting ducts microperfused in vitro were exposed to two different 
concentrations of luminal prorenin that had previously been shown to induce cellular 
responses in other preparations [50,51]. However, we detected no differences 
between tubules microperfused with prorenin or left untreated in the realkalinization 
rates after washing out the NH4Cl prepulse. The rate of realkalinization represents 
mostly proton extrusion by H+-ATPases as indicated by its sensitivity to typical H+-
ATPase inhibitors such as bafilomycin or concanamycin [20,29,68]. Moreover, we 
and others have previously shown that various stimuli including aldosterone, 
angiotensin II, or cAMP can stimulate H+-ATPase activity in such preparations 
[12,13,20,21,69].  In a previous study using MDCK cells as model for intercalated 
cells we had shown that prorenin was able to stimulate H+-ATPase activity, albeit at 
high concentrations, and that siRNA mediated suppression of (P)RR/Atp6ap2 
expression reduced expression of the a2 but not the a4, d2, and B1/2 H+-ATPase 
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subunits and diminished stimulation of H+-ATPase activity by the antidiuretic 
hormone [51]. The discrepancy between our present study and the previous 
experiments in MDCK cells may be explained by differences in the composition of 
proton pump subunits present in MDCK and the native murine cortical collecting duct 
or by more general differences between the MDCK cell culture system and freshly 
isolated intercalated cells. Some subclones of the original MDCK cell line, namely the 
C7 and C11 clones, are believed to resemble principal and intercalated cells [28]. 
However, we performed qPCR for typical markers expressed by intercalated cells 
(e.g. pendrin, AE1, Foxi1, CP2L1, B1/ATP6V1B1) and by principal cells (e.g. AQP2) 
on these clones and found only very low or inconsistent expression of specific 
intercalated cell markers in these clones (Kampik, Wagner, unpublished data) 
suggesting that MDCK cells may not represent a very faithful model to investigate 
intercalated cell functions and regulation. Along the same line, Advani et al had 
reported that incubation of MDCK cells with renin and prorenin stimulated ERK1/2 
phosphorylation and that this effect was blocked by the H+-ATPase inhibitor 
bafilomycin [50]. We thus incubated freshly isolated cortical collecting ducts and 
MDCK cells with prorenin. In both preparations, cortical collecting ducts and MDCK 
cells, only a weak but not significant increase of ERK1/2 phosphorylation was found. 
In freshly isolated murine collecting ducts ERK1/2 participates in the stimulatory 
effect of aldosterone on H+-ATPase activity [13]. Hence, an increase in pERK1/2 
might directly stimulate H+-ATPase activity or be permissive for other positive stimuli. 
Therefore, the absence of a stimulatory effect of prorenin on H+-ATPase activity is 
consistent with the absence of an effect on ERK1/2 phosphorylation in the same 
preparation and possibly also in MDCK cells. Of note, all batches of prorenin were 
extensively tested for in vitro activity before use in microperfusion or in vitro 
incubation experiments ruling out that an inactive form of prorenin was used [70,71]. 
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In summary, we extend previous observations on the localization of the 
(P)RR/Atp6ap2 along the entire murine nephron and provide detailed information on 
its subcellular localization in the various types of intercalated cells. (P)RR/Atp6ap2 
and two other H+-ATPase subunits did not show coordinated regulation of mRNA and 
protein expression in kidneys from mice receiving different treatments. Nevertheless, 
immunolocalization of (P)RR/Atp6ap2 and the a4/Atp6v0a4 H+-ATPase subunit 
showed colocalization under all conditions suggesting that (P)RR/Atp6ap2 may be 
closely linked to or an integral part of the pump. In freshly isolated collecting ducts, 
prorenin had no effect on basal H+-ATPase activity and ERK1/2 phosphorylation 
indicating that prorenin and possibly also renin are not directly regulating H+-ATPase 
activity under the conditions used in this assay. Whether prorenin may have a 
permissive effect on the regulation of H+-ATPase function by other stimuli cannot be 
ruled out. Our data do not provide any answer to the question whether the 
(P)RR/Atp6ap2 is a functionally relevant part of the H+-ATPase in the proximal tubule 
or intercalated cells. Experiments in Drosophila suggest that the (P)RR/Atp6ap2 
might participate in endocytic retrieval of proteins from urine in the proximal tubule 
[22]. Genetic deletion of (P)RR/Atp6ap2 in other tissues and cells suggests that the 
absence of (P)RR/Atp6ap2 impairs the expression and function of the proton pump 
complex [44,51,72]. Also, the genetic deletion of (P)RR/Atp6ap2 from the entire 
collecting duct in mice causes hydronephrosis and more alkaline urine consistent 
with an important role of the protein in the collecting duct [73]. The timed and specific 
deletion of (P)RR/Atp6ap2 from renal cells will have to address the specific 
function(s) of the (P)RR/Atp6ap2 in these cells and its relationship to H+-ATPase 
function. 
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FIGURE LEGENDS 
Figure 1. Expression of (P)RR/Atp6ap2 mRNA along the mouse nephron 
Nephron segments were dissected from mouse kidney and relative mRNA 
abundance of the (P)RR and the B1 (Atp6v1b1) subunit of the vacuolar H+-ATPase 
assessed. Segment-specific enrichment of nephron fragments was tested by qPCR 
for various transcripts: Podoplanin for the glomerulum, NaPi-.IIa for the S1 /S2 , S3 
segments of the proximal tubule and DCT, NKCC2 for the TAL, NCC for the DCT, 
AQP2 for the collecting duct system, and pendrin for the CNT/CCD. Data are mean ± 
SEM (n= 4 mice/segments). Glom glomerulus, S1/S2 convoluted part of the proximal 
tubule, S3 straight part of the proximal tubule, thin limb thin descending and 
ascending limb of the loop of Henle, TAL thick ascending limb of the loop of Henle, 
DCT distal convoluted tubule, CNT/CCD connecting tubule/cortical collecting duct, 
OMCD outer medullary collecting duct, IMCD inner medullary collecting duct, WT M 
12 wk C57BL/6 male mouse 12 weeks old.   
 
Figure 2. Localization of the (P)RR/Atp6ap2 in mouse kidney 
Immunoflourescence staining for the (P)RR/Atp6p2 in mouse kidney (green). (A) 
Overview showing (P)RR/Atp6ap2 (green), the principal cell specific AQP2 water 
channel (red), and nuclei (blue), original magnification 40 x. (B) A cortical field with 
glomerulus (G), and (P)RR/Atp6ap2 staining (green) in the proximal tubule (PT) and 
connecting tubules (CNT), 400 x magnification. (C) Cortical and outer medullary 
collecting duct stained for (P)RR/Atp6ap2 (green) and the principal cell specific AQP2 
water channel (red), 400 x magnification. (E,D,F) (P)RR staining (D: green) was 
detected in the proximal tubule (PT) in the brush border membrane and colocalized 
with the a4 H+-ATPase subunit (ATP6V0A4)(E: red) as indicated by the yellow color 
(F), original magnification 400x.  
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FIGURE 3 
Colocalization of the (P)RR/Atp6ap2 with the a4 H+-ATPase subunit in 
intercalated cells 
Staining of mouse kidney sections with antibodies against the a4 (Atp6v0a4) H+-
ATPase subunit (red, upper panels) and the (P)RR/Atp6ap2 (green, middle panels) 
demonstrates colocalization (yellow, lower panels) in intercalated cells at the light 
microscopy level. Original magnification 400x.  
 
FIGURE 4 
Subcellular localization of the (P)RR/Atp6ap2 in type A and non-type A 
intercalated cells 
(A,B) Staining of mouse kidney sections with antibodies against the (P)RR/Atp6ap2 
(green), the type A intercalated cell specific marker AE1 (red) and nuclei with DAPI 
(blue). In cells expressing AE1, (P)RR/Atp6ap2 related staining is found and localizes 
to the apical side of cells (insert in B), original magnification 630-1000 x. (C,D) 
Staining of mouse kidney sections with antibodies against the (P)RR/Atp6ap2 
(green), the non-type A intercalated cell specific marker pendrin (red) and nuclei with 
DAPI (blue). In cells positive for pendrin, (P)RR/Atp6ap2 staining is detected either at 
the basolateral side of cells (asterisks in D) and/or luminal side (yellow overlay, arrow 
in D). Original magnification 400 - 630 x. 
 
 
 
FIGURE 5 
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Regulated mRNA expression of (P)RR/Atp6ap2 and the B1/Atp6v1b1 and 
a4/Atp6v0a4 H+-ATPase subunits in mouse kidney.  
Mice were treated with NaCl, NaHCO3, KHCO3, NH4Cl or DOCA for 7 days, and 
relative mRNA expression levels of (P)RR/Atp6ap2, and the B1/Atp6v1b1 and 
a4/Atp6v0a4 H+-ATPase subunits were assessed by semi-quantitative real-time RT-
PCR in cortex and medulla. N = 5 animals/ group, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. 
 
FIGURE 6 
Regulated protein abundance of (P)RR/Atp6ap2 and the B1/Atp6v1b1 and 
a4/Atp6v0a4 H+-ATPase subunits in mouse kidney cortex.  
Mice were treated with NaCl, NaHCO3, KHCO3, NH4Cl or DOCA for 7 days, and 
protein expression levels of (P)RR/Atp6ap2, and the B1/Atp6v1b1 and a4/Atp6v0a4 
H+-ATPase subunits were examined by immunoblotting of total membrane fractions 
prepared from kidney cortex (A). All blots were stripped and reprobed for β-actin. (42 
kDa), and the ratio of (P)RR : β-actin was calculated. Bar graphs (B) summarize data 
from the blots. Arithmetic means ± SD are shown, n = 5 animals/ group, *p ≤ 0.05, 
**p ≤ 0.01, ***p ≤ 0.001. 
 
FIGURE 7 
Regulated protein abundance of (P)RR/Atp6ap2 and the B1/Atp6v1b1 and 
a4/Atp6v0a4 H+-ATPase subunits in mouse kidney medulla.  
Mice were treated with NaCl, NaHCO3, KHCO3, NH4Cl or DOCA for 7 days, and 
protein expression levels of (P)RR/Atp6ap2, and the B1/Atp6v1b1 and a4/Atp6v0a4 
H+-ATPase subunits were examined by immunoblotting of total membrane fractions 
prepared from kidney outer and inner medulla (A). All blots were stripped and 
reprobed for β-actin. (42 kDa), and the ratio of (P)RR to β-actin was calculated. Bar 
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graphs (B) summarize data from the blots. Arithmetic means ± SD  are shown, n = 5 
animals/ group, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. 
 
FIGURE 8 
Colocalization of (P)RR/Atp6ap2 and the a4/Atp6v0a4 H+-ATPase subunit under 
conditions of acidosis and alkalosis 
Mice were left untreated or received NH4Cl (0.28 M) or NaHCO3 (0.28 M) in drinking 
water for 7 days to induce metabolic acidosis or alkalosis, respectively. Kidney 
sections were stained with antibodies against the (P)RR/Atp6ap2 (green), the 
a4/Atp6v0a4 H+-ATPase subunit (red), the type A intercalated cell specific anion 
exchanger AE1 (white), and with DAPI (blue) to mark nuclei. (A-C) Kidney sections 
from control mice with a cortical field (A) (400x), convoluted proximal tubules (B)(630 
x), and  an outer medullary collecting duct (C)(630x). The insert in (C) shows a higher 
magnification of type A intercalated cells in the outer medulla. (D-F) Kidney sections 
from mice receiving NH4Cl showing a cortical field (D) (400x), convoluted proximal 
tubules (E)(630 x), and  an outer medullary collecting duct (F)(630x). The insert in (F) 
shows a higher magnification of type A intercalated cells in the outer medulla. (G-I) 
Kidney sections from mice treated with NaHCO3 showing a cortical field (G) (400x), 
convoluted proximal tubules (H)(630 x), and  an outer medullary collecting duct 
(I)(630x). The insert in (I) shows a higher magnification of type A intercalated cells in 
the outer medulla. N = 4 animals/group.  
 
 
 
 
FIGURE 9 
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Prorenin does not acutely stimulate H+-ATPase activity in microperfused 
mouse outer medullary collecting ducts 
Cortical collecting ducts were prepared by hand-dissection from mouse kidney and 
microperfused ex vivo. H+-ATPase activity was assessed from pHi recovery rates in 
BCECF loaded intercalated cells using the NH4Cl prepulse technique. 1 nM or 20 pM 
Prorenin was applied from the luminal side and pHi recovery rates were measured. N 
= 4 to 6 tubules/group  
 
FIGURE 10 
Prorenin stimulates ERK1/2 phosphorylation in isolated mouse collecting 
ducts and MDCK cells  
(A) Outer medullary collecting ducts were prepared by hand-dissection from kidneys 
of mice expressing EGFP under the control of the intercalated cell specific Atp6v1b1 
promoter [26] and incubated in vitro with or without prorenin for 10 min. Immunoblots 
were performed for pERK1/2 and total ERK1/2. (B) Three independent experiments 
were performed and are summarized as bar graph showing the ratio of pERK1/2 over 
total ERK1/2. (C, D) MDCK cells were incubated for 10 minutes with prorenin (20 nM) 
or angiotensin II (10 nM) in the absence or presence of the AT1 and AT2 receptor 
blockers losartan (10 µM) and PD123310 (10 µM). Immunoblots were performed for 
pERK1/2 and total ERK1/2. Three independent experiments were performed and are 
summarized as bar graph showing the ratio of pERK1/2 over total ERK1/2. 
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Supplementary table 1 
Sequences of forward and reverse primers and probes used for semi-quantitative 
real-time RT-PCR. 
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Supplementary Table 1: Primer and probe sequences 
Forward and reverse primers and probes used for semi-quantitative real-time RT-
PCR 
 
 
Primer 
Fw 
Probe 
Rv 
(P)RR 
5' ACG CAG TGG TAG AGT TAG TGA CTG 3' 
5' TCC TTG AGG CAA AAC AAG AGA ACA CCC 3' 
5' AGT TGA AAA CCA CTG AAT ACT CCA A 3' 
ATP6V1B1 
5' AGG ACA GTG TGC AGC GTC AAT 3' 
5' CCC AGT ATG CTG AGA TTG TCA ACT TTA CCC TCC 3' 
5' CCT GAA CAA TGG CCT TGG TC 3' 
ATP6V0A4 
'5' AGC CAA GCA CCA GAA ATC TCA 3' 
'5' CTG CAG TCT TTC ACG ATC CAC GAG GA 3' 
'5' GAG TGG TCA CCC TCC ACA GC 3' 
NaPi2a 
5' TGA TCA CCA GCA TTG CCG 3' 
'5' CCA GAC ACA ACA GAG GCT TCC ACT TCT ATG TC 3' 
5' GTG TTT GCA AGG CTG CCG 3' 
Podoplanin 
(Pdpn) 
Mm00494716_m1 (Applied Biosystem)  
NCC 
5' GGC TTT GCA GAA ACC GTA AGG 3' 
'5' TAC TGC AGG AGT ATG GCA CAC CCA TCG TA 3' 
5' ACA CCG ATG ATG CGG ATG T 3' 
NKCC2 
5' TCA CCA CCG TGG CCT ACA TA  3' 
'5' CTA TTT GCG TAG CCG CCT GTG TGG TC 3' 
5' TTC ATG CTG CCA GTG GCA  3' 
Pendrin 
5' GCC TTT GGG ATA AGC AAC GTC 3' 
5' TGG ATT TTT CTC CTG TTT TGT GGC TAC CAC T 3' 
5' CAA CGA TGG CAA CCA TCA CA 3' 
AQP2 
5' TGG TGC TGT GCA TCT TTG CCT 3' 
5' ACC TCC TTG GGA TCT ATT TCA CCG G 3' 
5' ACT TGC CAG TGA CAA CTG CTG 3' 
HPRT 
 
5' TTA TCA GAC TGA AGA GCT ACT GTA ATG 
ATC 3' 
5' TGA GAG ATC ATC TCC ACC AAT AAC TTT TAT GTC CC 3' 5' TTA CCA GTG TCA ATT ATA TCT TCA ACA 
ATC 3' 
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ABSTRACT 
 
 
 
The (Pro) renin receptor (P)RR)/ ATP6ap2 associates with H+-
ATPases which regulate organellar, cellular, and systemic acid-base 
homeostasis. In kidney, the (P)RR/ATP6ap2 colocalizes with H+-ATPases in 
various cell types including the cells of the proximal tubule.  There, H+ 
ATPases are involved in receptor-mediated endocytosis of low molecular 
weight proteins via the megalin/cubilin receptors. To study ATP6ap2 function 
in the proximal tubule, we used an inducible shRNA Atp6ap2 knockdown rat 
model (Kd) and an inducible kidney specific Atp6ap2 knockout mouse model 
(Flox(P)RRPax8+). Both animal lines showed higher proteinuria with elevated 
albumin, vitamin D binding protein, and procathepsin D in urine. Endocytosis 
of an injected fluid phase marker (FITC- dextran, 10 kDa) was normal 
whereas processing of recombinant transferrin, a marker for receptor 
mediated endocytosis, to lysosomes was delayed. Furthermore, expression of 
several proteins including several subunits of the H+-ATPase and the 
chloride/proton exchanger ClC-5 involved in receptor-mediated endocytosis 
was reduced. Expression of megalin and cubilin is not affected in both animal 
models. Lysosomal integrity and H+-ATPase function is associated with 
mTOR signaling. In (P)RR/ATP6ap2 knockout mice the mTOR–p70S6-kinase 
pathway was downregulated along with increased abundance of the LC3-B 
subunit of the autophagosome suggesting a more generalized impairment of 
lysosomal function in the absence of the (P)RR/ATP6ap2. Hence, our data 
suggests a role for ATP6ap2 for proximal tubule function in the kidney with a 
defect in receptor-mediated endocytosis in mice and rats. 
  
  
		
 
INTRODUCTION 
 
 
 
The (pro)renin receptor ((P)RR) was identified as the receptor for 
(pro)renin and renin 1-2. However, (P)RR expression is found also in 
organisms lacking a renin-angiotensin system suggesting additional functions 
1, 3-5 . The (P)RR is an essential adaptor protein in the canonical Wnt signaling 
pathway 6 and participates also in non-canonical Wnt signaling 7-9 10-12. In 
humans, mutations in (P)RR cause epilepsy and intellectual impairment 13.  
 
The (P)RR has been recognized to be identical to the M8-9 protein, a 
potential accessory subunit of H+-ATPases and is thus also known as 
ATP6ap2 14. Additional studies confirmed protein-protein interactions between 
the (P)RR and H+-ATPases 15.   
 
H+-ATPases, are multi-subunit complexes that mediate the transport of 
protons driven by hydrolysis of ATP. H+-ATPases are composed of a 
membrane bound V0 domain and a cytoplasmic V1 domain. Its location is 
mainly in intracellular organelles like endosome, lysosomes, golgi membrane 
and secretory vesicles but it can also be found in the plasma membrane in 
organs like kidney, epididymis, and bone 16-17. H+-ATPase are fundamental for 
acidification of late endosomes and lysosomes allowing membrane trafficking, 
protein degradation, and protein maturation 16, 18-19 . The (P)RR shares H+-
ATPase location in the plasma membrane of renal and other cells 20-23 but 
also in intracellular organelles 24. The importance of H+-ATPases in 
endocytosis was further confirmed in studies in mice lacking the V0 domain 
H+-ATPase a4 subunit in the kidney 25-26. These animals presented a 
generalized impairment of proximal tubule functions with glycosuria, 
phosphaturia and lysosomal defects. Similarly, humans and mice with 
mutations or loss of the ClC-5 chloride/proton exchanger, critical for lysosomal 
acidification and thought to work in tandem with endosomal and lysosomal H+-
ATPases, show impaired endocytosis and lysosomal function 27-29. Also in 
		
other organs, H+-ATPase mediated acidification of lysosomes and 
autophagosomes is critical for their function 30. 
 
The (P)RR/ATP6ap2 has been also linked to endocytosis in mouse and 
drosophila models. Conditional knockout mice for (P)RR in podocytes and 
cardiomyocytes exhibit accumulation of autophagic vesicles suggesting 
lysosomal defects 23, 31. In addition, embryonic fibroblast and podocyte cells in 
which (P)RR was deleted showed a down-regulation of several V0 H+-ATPase 
subunits 22. In drosophila, deletion of (P)RR impaired Wnt signaling by 
reducing endosomal recycling of frizzled-related receptors, and reduced fluid-
phase endocytosis, both functions linked to reduced H+-ATPase activity 8. 
 
The kidney proximal tubule is among the most active endocytic tissues 
reabsorbing a large variety of proteins, small peptides, and peptidomimetic 
drugs via receptor-mediated and fluid-phase endocytosis 32. Receptor-
mediated endocytosis requires the presence and function of the endocytic 
receptors megalin and cubilin expressed in the brush border membrane and 
endocytic apparatus. Moreover, efficient acidification of the endocytic pathway 
is critical for recycling and processing of proteins, activation of lysosomal 
enzymes and transporters, and lysosomal signaling via the mammalian target 
of rapamycin (mTOR) pathway 33-35 . Several of these processes have been 
shown to be H+-ATPase dependent 18, 36  . 
 
 
To date, the role of (P)RR/ATP6ap2 in the proximal tubule has not 
been elucidated. Here, we investigated (P)RR/ATP6ap2 function in proximal 
tubule using two different animal models. A rat model with an inducible 
shRNA for Atp6ap2 and an inducible kidney epithelial cell-specific knockout 
mouse for (P)RR/ATP6ap2. We report that (P)RR/ATP6ap2 plays a role in 
cargo reabsorption and processing via receptor mediated endocytosis, hence, 
contributing to kidney proximal tubule function.  
 
  
		
RESULTS 
 
Knock-down of (P)RR/Atp6ap2 in rats 
  Transgenic rats (Sh rats) expressing an shRNA against the (P)RR/ 
Atp6ap2 were generated by inserting a transgene under the control of 
tetracycline repressor protein (TetR) allowing the controlled activation of the 
shRNA by doxycycline treatment (Figure 1A). Integration of the transgene and 
expression of the TetR mRNA and protein was confirmed by PCR (Figure 1B) 
and immunoblotting (Figure 1C). We could detect TetR protein in all organs 
tested. Expression of (P)RR/Atp6ap2 protein and mRNA were studied in more 
detail in the kidney from animals 10 days after doxycycline treatment. RT-
qPCR for Atp6ap2 mRNA in whole kidney showed a decrease by approx. 90 
% of the transcript in Sh rats when compared with control rats (Wt) (Figure 
1D). Similarly, immunohistochemistry on kidney sections stained for the 
(P)RR/ATP6ap2 and the H+-ATPase subunit a4 (Figure 1E) demonstrated 
greatly reduced or absent (P)RR/ATP6ap2 related staining in proximal tubule 
and intercalated cells. H+-ATPase subunit a4 staining was used as a positive 
control, since both proteins share the same localization in the kidney 21. Thus, 
Atp6ap2 shRNA rats present with an efficient knock-down of Atp6ap2/(P)RR 
mRNA and protein in kidney. 
 
 At the level of light microscopy, similar overall renal morphology was 
seen in Wt and Sh rats (Figure 1F). However, in Sh rat kidneys, we could 
observe some areas containing vacuoles, suggesting degeneration of some 
nephrons. Such areas were less seen in Wt kidneys. The gross morphology of 
glomeruli was undistinguishable between Wt and Sh rats unlike in mice with 
podocyte specific deletion of the (P)RR/ATP6ap2 23, 31.  
 
 Body weight, food and water intake, were not different in Wt and Sh 
rats 10 days after doxycycline treatment. Urine and blood analysis revealed 
normal electrolytes and pH. BUN and blood phosphate levels were elevated in 
Sh rats whereas creatinine clearance decreased consistent with a mild 
impairment of renal function. In urine, sodium levels were lower while 
		
phosphate and creatinine excretion was increased in Sh rats (Supplementary 
table 1). 
 
  
(P)RR/ATP6ap2 knock-down impairs proximal tubule receptor-mediated 
endocytosis 
 Sh rats exhibited mild albuminuria and low molecular weight proteinuria 
as indicated by elevated vitamin D binding protein (VDBP) in urine (Figure 
2A,B). To further determine which endocytic pathway may be impaired, we 
coinjected in both animal groups a marker for fluid endocytosis (dextran-FITC, 
10 kDa) and a marker for receptor-mediated endocytosis (human transferrin) 
and fixed kidneys for immunohistochemistry 10 and 40 min. after injection. 
Dextran-FITC was co-stained with phalloidin (marker for the brush border 
membrane) to allow subcellular determination of dextran localization. By 
immunohistochemistry, no differences were observed in FITC intensity or 
subcellular localization between animal groups at 10 min. In addition, the 
relative amount of FITC in kidney tissue at 10 min. was similar between 
animal groups (Figure 2D). Dextran-FITC at 40 min. was also analyzed 
(Supplementary figure 1) and staining intensity was weaker than at 10 min. 
but showed similar subcellular localization in both genotypes. Thus, fluid-
phase endocytosis is not affected by (P)RR/AT6ap2 knock-down.   
In contrast, endocytosis of human transferrin was altered in Sh rats 
compared to Wt animals. We used antibodies recognizing human but not 
endogenous rat or mouse transferrin and detected a weaker transferrin 
related staining in kidneys from Sh rats 10 min. after injection whereas 40 
min. after injection more pronounced staining was found in Sh rat kidneys 
than in Wt kidneys (Figure 2E). At 10 min. transferrin was localized in the 
subapical region and presented as a punctuated pattern as expected  37. 
Immunoblotting for human transferrin in urine samples collected 10 min. after 
transferrin injection showed abundant transferrin in urine from Sh rats but very 
low levels in Wt urine suggesting reduced uptake (Figure 2F). Forty min. after 
injection, in Wt rats transferrin staining was almost absent while in the Sh rats 
transferrin staining accumulated in the perinuclear region (Figure 2E).  
		
 The localization of the two major endocytic receptors megalin and 
cubilin was similar in both genotypes at light microscopy level (Figure 2E and 
supplementary figure 2). The relative amount of megalin protein was 
unchanged whereas cubilin was more abundant in kidneys from Sh rats 
(Figure 3). 
 (P)RR was suggested to be an accessory subunit of H+-ATPases 1, 14, 
38 therefore a loss of (P)RR/ATP6ap2 could affect H+-ATPase regulation 
and/or function in the endocytic pathway. Immunoblotting showed reduced a4 
H+-ATPase (ATP6V0a4) subunit whereas B2 (ATP6V1B2) and A (ATP6V1A) 
subunits were unaltered (Figure 3). The ClC5 chloride/proton exchanger  
involved in endocytic and lysosomal acidification in the proximal tubule was 
upregulated 28-29, 39-40.    
The abundance of NaPi-IIa, the main phosphate transporter in the 
proximal tubule, and NHE3 (sodium-proton exchanger 3) is directly or 
indirectly affected by alterations in the endocytic apparatus of the proximal 
tubule 41-43 NaPi-IIa showed no differences in abundance and NHE3 a slight 
increase in expression, however, not reaching significance due to high 
interindividual variability (Figure 3).  
 
Kidney-epithelial cell specific (P)RR/ATP6ap2 KO mice 
 
Since Atp6ap2 shRNA rats present with a full body knock-down of the 
(P)RR/ATP6p2 that may impact on overall renal function and that complicates 
interpretation of data, we decided to examine proximal tubular endocytosis in 
a kidney-epithelial cell specific inducible (P)RR/ATP6ap2 knock-out (KO) 
mouse model using the well described doxycycline-inducible Pax8-Cre 
system after crossing with floxed (P)RR/ATP6ap2 mice. We used a milder 
induction protocol for Cre activity 44 as usual based on previous experience 
suggesting that higher doses of doxycyline can also produce effects in 
wildtype mice and with the intention to downregulate (P)RR/ATP6ap2 mostly 
in proximal tubules without producing the strong phenotype caused by 
deletion of (P)RR/ATP6ap2 in the collecting duct 45-47. To verify kidney-
specific (P)RR/ATP6ap2 deletion, we performed RT-qPCR for Atp6ap2 in the 
		
kidney, lung and heart (Figure 4A). Atp6ap2 was downregulated only in 
kidneys from Flox/Pax8+ mice but not in other organs or kidneys from control 
Wt/Pax8+ mice. Western blotting using total kidney protein homogenate 
confirmed reduction of (P)RR/ATP6ap2 protein expression by about 75 % 
(Figure 4B). Residual mRNA and protein expression may be due to 
expression in renal cells negative for Pax8 (i.e. podocytes) or incomplete 
deletion in epithelial cells.  Immunohistochemistry using three different 
antibodies against the (P)RR/ATP6ap2 demonstrated almost complete 
deletion of the (P)RR/ATP6ap2 from proximal tubules but widely preserved 
staining in intercalated cells of the connecting tubule and medullary collecting 
ducts (Figure 4C and supplementary figures 3 and 4).  
Flox/Pax8+ mice had normal blood acid-base and electrolyte status 
and no evidence for reduced kidney function unlike rats. Urine analysis 
showed higher diuresis and mild sodium and potassium losses with reduced 
urinary calcium excretion consistent with the deletion of the (P)RR/ATP6ap2 
mostly from proximal tubules (Supplementary table 2).  
 
(P)RR/ATP6ap2 deletion in proximal tubule causes a defect in receptor-
mediated endocytosis 
 
 Like the rat model, Flox/Pax8Cre+ mice had albuminuria and low 
molecular weight proteinuria loosing VDBP and procathepsin B with urine 
(Figure 5). Coinjection of the endocytic markers dextran-FITC (10 kDa) and 
human transferrin confirmed that deletion of the (P)RR/ATP6ap2 affects the 
receptor mediated endocytosis pathway (Figure 6).  Dextran-FITC localization 
and intensity of staining was similar between animals groups at two time 
points (10 and 40 min. after injection). Human transferrin staining was similar 
between genotypes 10 min. after injection but showed, like in Sh rats, delayed 
clearance of transferrin in Flox/Pax8+ mice 40 min. after injection with 
perinuclear accumulation (Figure 6B). Costaining of human transferrin with 
Lamp1, a lysosomal marker, in kidneys 40 min. after injection (Figure 6C), 
revealed that in (P)RR/ATP6ap2 deficient animals human transferrin did not 
overlap with Lamp-1 stained lysosomes suggesting delayed transferrin 
processing (Figure 6C). 
		
 Western blotting demonstrated reduced expression of the a4 
(ATP6V0a4) and EII (ATP6V1EII) H+-ATPase subunits whereas the a2 
(ATP6V0a2) and A (ATP6V1A) subunits showed a strong trend to be lowered. 
ATP6V1B2 protein abundance was unaltered. Megalin, cubilin and NHE3 
abundance was not altered but ClC5 expression was strongly reduced (Figure 
7).   
  mTOR signaling is linked to lysosomal function 36, 48-49 . Vice versa, 
inhibition of mTOR by rapamycin in mice caused megalin downregulation and 
proteinuria through a H+-ATPase dependent mechanism  50. In Flox/Pax8+ 
kidneys total mTOR amount was reduced (Figure 8) while phospho mTOR 
showed a trend for reduction. Importantly the down-stream effector p70 S6K 
showed no difference for total abundance but had reduced levels of activated 
phosphorylated p70 S6K consistent with reduced activity of the mTOR 
pathway (Figure 8).   
mTOR signaling as well as (P)RR/ ATP6ap2 are linked to autophagy 23, 
51-52. Staining for the microtubule-associated protein 1A/1B-light chain 3 or 
LC3-B, a subunit of the autophagosome showed accumulation of LC3-B in 
proximal tubules from (P)RR/ATP6ap2 deficient mice but not in wild type 
controls (Figure 9).  
  
		
DISCUSSION 
In this study, we revealed that (P)RR/ATP6ap2 plays a role in receptor-
mediated endocytosis and lysosomal function in the proximal tubule. Both 
ATP6ap2-Sh rats and Flox(P)RR/Pax8Cre+ mice showed excretion of 
albumin and low molecular weight proteins in urine, delayed processing of 
substrates of the receptor-mediated endocytosis pathway, reduced 
expression of other key molecules involved in this process as well as 
downregulation of the mTOR pathway and accumulation of the LC3-B subunit 
of the autophagosome. All these changes are consistent with impaired 
lysosome function and reduced activity of the receptor-mediated endocytosis 
pathway. 
 
We used two rodent models to demonstrate a role of the 
(P)RR/ATP6ap2 in proximal tubule endocytosis of low molecular weight 
proteins and lysosomal function. Both models yield similar results as 
discussed below in more detail. The mouse model used is similar to 
previously published models with a more severe renal defect including an 
urinary concentration defect, salt loss, and distal renal tubular acidosis 45-47. A 
major difference between these models our model is that we used a milder 
protocol 44 to induce Cre activity and deletion of the (P)RR/ATP6ap2 which 
resulted only in an almost complete deletion in the proximal tubule but with 
well preserved expression in the collecting duct thereby circumventing a more 
severe renal damage and phenotype allowing to focus on proximal tubule 
functions.   
 (P)RR/ATP6ap2 associates with H+-ATPases 6, 14-15, 53. We and others 
had shown that the (P)RR/ATP6ap2 is expressed in the renal proximal tubule 
and colocalizes with H+-ATPases in this nephron segments and others 21, 54-55. 
H+-ATPases contribute to several functions of the proximal tubule such as 
reabsorption of bicarbonate, trafficking and recycling of membrane proteins, 
or endocytosis of proteins from urine, acidification of vesicles along the 
endocytic pathway and lysosomes processing or degrading absorbed 
substrates.  
		
 Several lines of evidence suggest that the (P)RR/ATP6ap2 modulates 
H+-ATPase function in the proximal tubule and thereby contributes to 
receptor-mediated endocytosis and lysosomal function. However, our data do 
not support a role of the (P)RR/ATP6ap2 in fluid–phase mediated endocytosis 
as suggested by data from Drosophila 8 or other generalized functions of the 
proximal tubule. Urine analysis and immunoblotting showed no generalized 
Fanconi-syndrome like loss of function as indicated by the absence of 
glucosuria, massive proteinuria or changes in urine and blood pH. Both, Sh 
rats with reduced (P)RR/ATP6ap2 as well as (P)RR/ATP6ap2 KO mice, 
showed albuminuria in combination with the presence of low molecular weight 
proteins such as the vitamin D binding protein (VDBP) or procathepsin in 
urine indicative of reduced proximal tubular protein absorption. In case of the 
Sh rats, we cannot exclude also increased filtration of albumin as in these 
animals (P)RR/ATP6ap2 expression in podocytes may be reduced and 
podocyte specific deletion of (P)RR/ATP6ap2 causes massive proteinuria and 
glomerular damage 23, 31. Therefore, we created mice with deletion of the 
(P)RR/ATP6ap2 in the epithelial cells along the nephron with intact 
expression of the protein in podocytes and found similar urinary excretion of 
albumin, VDBP and procathepsin. Absorption of these proteins depends on 
the initial recognition by and binding to the multispecific receptors megalin and 
cubilin present in the brush border membrane 32. Deletion of the 
(P)RR/ATP6ap2 did not alter overall abundance of these receptors and 
affected also not their localization at the level of light microscopy. Proteins 
bound to these receptors are then internalized in a receptor-ligand complex 
and further processed through early endosomes to late endosomes and 
lysosomes. In our experiments, four different ligands of these receptors were 
further investigated: albumin and VDBP which are internalized by both 
megalin and cubilin, procathepsin B which is preferentially absorbed by 
megalin and transferrin a preferred substrate for cubilin 32. All four proteins 
were found at elevated levels in urine suggesting a defect common to both 
receptors. More detailed analysis of transferrin internalization showed that 
transferrin is taken up from urine, albeit at somewhat lower rates (as indicated 
by higher urinary excretion after injection of transferrin) and that processing of 
transferrin to lysosomes is delayed as suggested by accumulation of 
		
transferrin 40 min. after injection and much reduced colocalization of injected 
transferrin with a lysosomal marker at this later time point.  
 The delayed processing of endocytic substrates is most likely due to a 
reduced capacity of endocytic and lysosomal vesicles to acidify. A role of the 
(P)RR/ATP6ap2 in endosomal acidification has been described in Xenopus 
frog embryos and linked to reduced H+-ATPase activity 6. Consistently, we 
found decreased expression of several H+-ATPase subunits including the a4 
subunit (ATP6V0a4) in Sh rats and KO mice as well as the EII (ATP6V1EII) 
subunit in the KO mice. Similarly, ablation of the (P)RR/ATP6ap2 in 
embryonic cardiomyocytes reduced expression of several subunits of the V0 
domain of the H+-ATPase and impaired lysosomal acidification 22. In mice, 
deletion of ATP6V0a4 causes proximal tubular dysfunction and reduced 
receptor-mediated endocytosis with impaired lysosomal function consistent 
with an important role of H+-ATPases in these processes 26. Whether the 
lower expression of the a4 subunit in the (P)RR/ATP6ap2 deficient rodent 
models is the consequence of absent (P)RR/ATP6ap2 function and/or directly 
causes the endocytic and lysosomal defect remains unclear at this point. 
Moreover, reduced levels of the chloride/proton exchanger ClC-5 were found 
in (P)RR/ATP6ap2 KO mice. ClC-5 mutations cause Dent's disease which 
features also reduced receptor-mediated endocytosis and lysosomal defects 
in the proximal tubule due to a reduced capacity to acidify endosomes and 
lysosomes and reduced expression of the endocytic receptors megalin and 
cubilin 28-29, 56-59. In contrast, in the Sh rat model ClC-5 expression was 
upregulated. Thus, the endocytic defect exists also in the presence of 
elevated ClC-5 levels suggesting that the reduction of ClC-5 expression is 
rather the consequence of the defect than the cause. The reasons for the 
difference in ClC-5 expression between the two rodent models may be due to 
species differences or due to deletion of (P)RR/ATP6ap2 from podocytes and 
a mild glomerular phenotype in the Sh rats.  
 Defects in lysosomal acidification due to reduced or absent H+-ATPase 
function can cause altered mTOR signaling and activation of the 
autophagosome as in X-linked autophagic myopathy due to mutations in the 
		
VMA21 protein required for lysosomal H+-ATPase assembly 60 or in 
podocytes with specific deletion of the (P)RR/ATP6ap2 and impaired 
lysosomal function 23, 31. Fusion of lysosomes and autophagosomes occurs 
independently from lysosomal acidification but requires H+-ATPases 61. 
Lysosomes act as signaling platforms associating with the mTOR complex 1 
and H+-ATPase function is required for mTORC1 signaling whereas in turn 
mTOR signaling regulates H+-ATPase expression 62-63. mTOR is also a 
regulator of autophagosome function and autophagosome-lysosomal fusion 
and reduced mTOR signaling impairs autophagosome-lysosome fusion 64-65. 
Thus, deletion of the (P)RR/ATP6ap2 may impair H+-ATPase assembly and 
function, thereby decreasing endosomal and lysosomal acidification as well as 
mTOR signaling. Consequently, lysosome-autophagosome fusion may be 
decreased due to H+-ATPase dependent but acidification independent as well 
as mTOR dependent mechanisms. Of note, increased levels of the 
(P)RR/ATP6ap2 in a podocyte cell line enhance mTOR signaling and reduce 
autophagosome expression and activity 66. 
 
In summary, genetic deletion of the (P)RR/ATP6ap2 from the proximal tubule 
in rats and mice causes albuminuria and low molecular weight proteinuria 
paralleled by reduced expression of several H+-ATPase subunits and delayed 
processing of substrates of receptor mediated endocytosis to lysosomes. 
Lysosomal dysfunction is suggested by altered mTOR signaling and 
accumulation of the LC3-B subunit of the autophagosome. Thus, the 
(P)RR/ATPap2 facilitates receptor-mediated endocytosis in the proximal 
tubule possibly by modulating H+-ATPases.  
 
  
		
METHODS 
 
Animals 
  
Generation and breeding of transgenic Atp6ap2 shRNA rats 
 Transgenic rats were generated as described previously 67. Briefly, 
complementary sense and antisense oligonucleotides (rAtp6ap2sh3: 5’- TCC 
CCC TAC AAC CTT GCG TAT AAT TCA AGA GAT TAT ACG CAA GGT 
TGT AGG TTT TTT A -3’ and rAtp6ap2sh4: 5’- CGC GTA AAA AAC CTA 
CAA CCT TGC GTA TAA TCT CTT GAA TTA TAC GCA AGG TTG TAG G -
3’) specifically targeting a sequence in the exon 9 of the rat (P)RR/Atp6ap2 
mRNA, were annealed and cloned into the bimodal pINV7 vector (Taconic) 
using the BbsI and MluI restriction sites.  
 To generate transgenic rats, a 4 kb DNA fragment containing pTet-
shAtp6ap2 (Figure 1A) was cut out with the PacI and KpnI restriction 
enzymes, purified from the gel using a Wizard® SV Gel and PCR Clean-Up 
System (Promega), dissolved at 3 ng/µl with microinjection buffer (8 mM Tris-
HCl, pH 7.4 and 0.15 mM EDTA) and microinjected into fertilized oocytes of 
Sprague-Dawley (SD) rats according to established techniques 68. Integration 
of the transgene was detected by PCR in genomic DNA isolated from tail 
biopsies with the primers TetOfw: 5' -TGC ATG TCG CTA TGT GTT CT -3' 
and CAGGSrv: 5′- TGG CGT TAC TAT GGG AAC AT -3′. Using one positive 
newborn, the transgenic line ShAtp6ap2 was then established on the SD 
background. Negative littermates were used as wild type (Wt) controls.  
 Rats were maintained in individually ventilated cages under 
standardized, pathogen-free conditions (at a temperature of 21 ± 2°C,  
humidity of 65 ± 5% and with an artificial 12 h light/dark cycle) with free 
access to standard chow (0.25% sodium; SSNIFF) and drinking water ad 
libitum. All animal care and experiments were performed in accordance with 
the institutional guidelines of German Federal Law and local authorities of 
Berlin (LaGeSo). 		
Doxycycline treatment of rats in vivo 
		
 To induce expression of shRNA against (P)RR/ATP6ap2, animals were 
treated with 0.5 g/l doxycycline (Sigma) in the drinking water for 8 days. The 
doxycycline water was freshly prepared each day and kept dark due to the 
light sensitivity. To confirm the functionality of the system, (P)RR/ATP6ap2 
protein and RNA levels were analyzed in organs by western blot and real time 
PCR, respectively. 
 
Western blotting to confirm shAtp6ap2 rats 
         Rats were anaesthetized with isofluorane followed by exsanguination. 
Tissues were collected, snap frozen in liquid nitrogen, coarsely ground using 
a mortar and pestle, and further homogenized in RIPA buffer (Cell Signaling) 
for protein extraction, using a FastPrep™-24 (MP Biomedicals) according to 
the manufacturers’ instructions. Total proteins were added to 4x Roti®-load 
buffer (Carl Roth) and separated by 12% SDS/PAGE. Proteins were then 
blotted on a PVDF membrane (Amersham Biosciences), which was 
subsequently blocked with Odyssey® Blocking Buffer and incubated with the 
following primary antibodies: mouse anti-TetR (1:8000, MoBiTec) and rabbit 
anti-GAPDH (1:1000, Cell Signaling). Protein revelation was performed with 
an Odyssey® Infrared imaging system (LI-COR Biosciences) using IRdye® 
800-coupled secondary antibodies (1:10000, LI-COR Biosciences).  
 
Kidney-epithelial cell specific (P)RR/ATP6ap2 KO mice generation 
 The generation and genotype of (P)RR/ATP6ap2flox/y has been already 
described 23. Heterozygous (P)RR/ATP6ap2 flox/x females were crossed with 
males both positive for Pax8-rtTA and Cre 44, 69. Expression of Cre-
recombinase was induced in male (P)RR/ATP6ap2flox/y,Pax8Cre+ and 
(P)RR/ATP6ap2+/+,Pax8Cre+ transgenic mice by 0.5 mg/ml of doxycycline 
(Sigma) in drinking water containing 2% of Sucrose (Sigma) for 5 days 
followed by 5 days induction with 0.25 mg/ml Doxycycline in 2% sucrose 
drinking water and 4 days without doxycycline 44. Animals used for 
experiments were 2 to 3 months old male mice bred in a C57BL/6 
background. All animal studies were performed according to Swiss welfare 
laws and with approval of the local veterinary authorities.  
		
 
Plasma and urine analysis 	 Blood was collected from the tail vein of anesthetized rats and vena 
cava from anesthetized mice. Heparinized blood was centrifuged at 7000 rpm 
for 7 min., plasma collected, and rapidly frozen. Measurements of blood pH, 
and blood electrolyte concentrations (Na+, K+, Cl-, Ca2+) were analyzed using 
an ABL80 FLEX CO-OX (Radiometer, Copenhagen) and performed on 
heparinized tail vein blood. Urine was collected under mineral oil for 24 hours 
in metabolic cages (Tecniplast®, Italy) and aliquots were rapidly frozen and 
stored at -80°C until measurement. Urine and plasma laboratory analyses 
were performed in the Zurich Integrative Rodent Physiology (ZIRP) core 
facility. 
 
RNA extraction and RT-qPCR 
 Harvested organs were snap frozen in liquid nitrogen. Total RNA was 
extracted using the Qiagen RNeasy Mini Kit (Qiagen, Hombrechtikon, 
Switzerland). Snap-frozen tissue slices were homogenized in a pestle 
homogenizer (Potter-Elvehjem type) together with 1 ml precooled RLT-Buffer 
supplemented with β -mercaptoethanol at a final concentration of 1 %. 
Subsequently, 350 µl of the homogenate were used for RNA preparation 
carried out according to the manufacturer's instructions. DNAse digestion was 
performed using the RNase-free DNAase Set (Qiagen; Hilden, Germany). 
Total RNA extractions were analysed for quality, purity, and concentration 
using the NanoDrop ND-1000 spectrophotometer (Wilmington, DE, USA). 
RNA samples were diluted to a final concentration of 100 ng/µl and cDNA was 
prepared using the TaqMan Reverse Transcriptase Reagent Kit (Applied 
Biosystems, Roche; Forster City, CA, USA). In brief, in a reaction volume of 
40 µl, 300 ng of RNA was used as template and mixed with the following final 
concentrations of RT buffer (1x), MgCl2 (5.5 mM), random hexamers (2.5 µM), 
dNTP mix (500 µM each), RNase inhibitor (0.4 U/µl), multiscribe reverse 
transcriptase (1.25 U/µl) and RNAse-free water. Reverse transcription was 
performed with thermocycling conditions set at 25°C for 10 min., 48°C for 30 
min., and 95°C for 5 min. on a thermocyler (Biometra, Goettingen, Germany). 
		
 Semi-quantitative real-time PCR (RT-qPCR) was performed on the ABI 
PRISM 7700 Sequence Detection System (Applied Biosystems). Primers for 
Atp6ap2 were designed using Primer Express software from Applied 
Biosystems and purchased from Microsynth, Switzerland. Probes were 
labelled with the reporter dye FAM at the 5'-end and the quencher dye 
TAMRA at the 3'-end (Microsynth, Balgach, Switzerland). 
For mus musculus RT-qPCR, the following pair of primers for Atp6ap2 were 
used forward 5’-GTGCTGGTCGTTCTCCTGTTC- 3’; reverse 5’-
GGGATTCGATCTCCTGGTATAG- 3’ together with a probe 
5’GTGGCGGGTGCTTTAGGGAATGAAT- 3’ which target only Atp6ap2 exon 
2. For rattus norvegicus Atp6ap2 RT-qPCR we used: forward 5’-
TCGGATCCTTGTTGATGCTCTC -3’; reverse 5’- 
CTCACCAGGGATGTGTCGAA- 3’ primers and 5’- 
TGGGAATGCAGTGGTAGAGTTGGTGA -3’ as probe. Real-Time PCR 
reactions were performed using TaqMan Universal PCR Master Mix (Applied 
Biosystems) as described in the manufacturer’s user manual. 		
Protein extraction and immunoblotting  
 Crude membrane and cytosolic proteins were extracted from half a 
kidney. Briefly, organs were homogenized in 200 µl of ice cold resuspension 
buffer (200 mM Mannitol, 80 mM HEPES, 41 mM KOH, pH 7.5 supplemented 
with 1 tablet/10 ml Complete Mini Protease Inhibitor Cocktail, Roche) using a 
Polytron homogenizer (0.5 mm diameter at 20'000 rpm for 1 minute at 4°C). 
The homogenate centrifuged at 2'000 rpm for 20 min. at 4°C. The resulting 
supernatant was further centrifuged at 41'000 rpm for 1 hour at 4°C. Brush 
border membrane protein preparation was performed according to the Mg2+ 
precipitation procedure 70. 
 Tissue and urine samples were normalized for protein or creatinine 
levels, respectively, diluted in Laemmli buffer, heated at 95° for 5 min. and 
separated by SDS-polyacrylamide gels electrophoresis on 8-12 % gels. For 
immunoblotting, proteins were transferred to polyvinylidene fluoride 
membranes (Immobilon-P, Millipore, Bedford, MA, USA). After blocking with 5 
% milk powder in Tris-buffered saline/0.1 % Tween-20 for 30 min., blots were 
		
incubated with the primary antibodies: rabbit anti-ATP6V0a4 serum (1:1000) 
71, rabbit anti-ATP6V0a2 (a kind gift of Dr. X. S. Xie, Dallas, TX, USA) 72-73, 
rabbit anti-ATP6V1B2 serum (1:5000 raised against the sequence 
EFYPRDSAKH, Pineda Berlin, Germany), mouse monoclonal anti-ATP6V1E2 
(1:1000, a kind gift of Dr. S. L Gluck, University of California, San Francisco, 
CA,USA) 74, rabbit anti-ClC-5 serum (1:1000, a kind gift from Dr. Olivier 
Devuyst, University of Zurich) 75, rabbit polyclonal anti-NaPi-IIa (1:5000) 76, 
sheep anti-Megalin (1:10.000, a kind gift from Dr. Olivier Devuyst, University 
of Zurich, Switzerland) 29, rabbit anti-cubilin (1:1000, a kind gift from Dr. Erik 
Ilsø Christensen, Aarhus University, Denmark), rabbit anti-VDBP (1:2500, 
Dako, A0021), rabbit-human transferrin (1:2000, Dako, A0061), rabbit anti-
NHE3 (1:1000,StressMarq,SPC-400D), rabbit anti-(P)RR (1:500,Sigma, 
HPA003156), rabbit anti-mTOR (1:1000, #2972, Cell Signaling Technology, 
Boston, MA, USA), rabbit anti-phospho-mTOR (1:1000, #2974, Cell Signaling 
Technology, Boston, MA, USA), rabbit anti-p70 S6K (1:1000, #2708, Cell 
Signaling Technology, Boston, MA, USA), mouse anti-phospho-p70 S6K 
(1:1000, #9206, Cell Signaling Technology, Boston, MA, USA), and mouse 
monoclonal anti-β-actin antibody (1:5000, A5441, Sigma,), either for 2h at 
room temperature or overnight at 4°C. Membranes were then incubated for 1h 
at room temperature with secondary anti-rabbit or ant-mouse antibodies 
linked to alkaline phosphatase (1:10'000, S373B, S372B, Promega, USA), or 
anti-sheep-antibodies coupled to HRP (1:20'000, Dako, P0163), or anti-
mouse-HRP (1:20'000, W402B, Promega, USA). The protein signal was 
detected with the appropriate substrates using the LAS 4000 (Fujifilm) 
detection system. All images were analyzed using the software Quantity One 
4.6.1 (Biorad) to calculate the protein of interest/β-actin ratio. 			
Immunofluorescence staining 	 Mouse and rat kidneys were perfused in situ through the left heart 
ventricle with a solution containing 10'000 IU Heparin-Na Solution (B. Braun 
Medical AG, Sempach, Switzerland), 2 ml Lidocain 1 % (Streuli Pharma AG, 
Uznach, Switzerland), 2 ml CaCl2, 16 %, 2 ml 0.9 % NaCl, and 2 ml distilled 
		
water. Subsequently, animals were perfused with 3 % paraformaldehyde in 
phosphate buffered saline (PBS). Fixed kidneys were cryoprotected with 2.3 
M sucrose (Sigma), embedded in TissueTec OCT compound 4583 (Sakura 
Finetek USA, Torrance, CA), and frozen in liquid nitrogen and stored at -80°C. 
Kidney cryosections were cut with 5 µm thickness on a Leica CM3050S 
cryostat (Leica Microsystems, Bannockburn, IL). Slides were rehydrated in 
PBS and treated either with 10 mM Tris (Trizma Base,Sigma), pH 10 at 100° 
for 20 min. in a pressure cooker (HistoPro, Millestone) or 10 mM  Citric acid 
(Sigma), pH 6.0 at 98°C for 20 min or 1 % Sodium dodecyl sulfate (SDS) in 
PBS.  In the case of Lamp1 staining, slides were quenched with 50 mM of 
NH4Cl in PBS, three times for 10 min. Unspecific sites were blocked with a 
solution containing 1X PBS/ 5% donkey serum (Sigma)/ 0.3% Triton X-100 
(Sigma) for 20 min. at room temperature. Primary antibodies were diluted in 
1X PBS/ 1% BSA/ 0.3% TritonX-100: goat polyclonal anti-(P)RR/ATP6AP2 
(1:100, Novus Biologicals, NB100-1318, used with SDS pretreatment); rabbit 
polyclonal anti-ATP6IP2 antibody (1:200, ABCAM ab40790, used with 
microwaving in citric acid), goat polyclonal anti-(P)RR antibody (1:100, R&D 
Systems, #AF5716, used with SDS pretreatment),  rabbit anti- ATP6V0a4 
serum (1:2000) 71, goat anti-megalin (1:600, Santa Cruz, sc-16478), rabbit 
anti-human transferrin (1:600, Dako, A006), rabbit anti-cubilin (1:700, kindly 
provided by Dr. Erik Ilsø Christensen, Aarhus University, Denmark), rat anti-
Lamp1 (1.1000, 1D4B was deposited to the DSHB by August, J.T. (DSHB 
Hybridoma Product 1D4B)), anti-rabbit LC3B (1:250, Cell Signaling 
Technology, # 2775), goat anti-AQP2 (1:400, Santa Cruz) or rabbit anti-AQP2 
(1:1000, kindly provided by Dr. J. Loffing, University of Zurich) and kidney 
sections were incubated with the primary antibodies overnight at 4°C. 
Sections were washed twice with hypertonic PBS (18 g/l NaCl/PBS) and once 
with 1X PBS. Afterwards sections were incubated with corresponding 
secondary antibodies (1:1000) (anti-goat Alexa594 and anti-goat Alexa488, 
anti-rat Alexa 647,anti-rabbit Alexa 488 and anti-rabbit Alexa594 (Invitrogen, 
Switzerland), phalloidin-Texas Red® (1:100, Molecular Probes), phalloidin-
A647 (1:1'000, Abcam, ab176759), and DAPI (1:1000, Invitrogen) for 1h at 
room temperature. Slides were washed twice with hypertonic PBS and then 
once with 1X PBS before being mounted with Dako glycergel mounting 
		
medium. Semi-thin section (200 nm thickness) were cut with an 
ultramicrotome (Leica Microsystems Leica EM FCS) and stained with 
Toluidine Blue O (T3260 Sigma-Aldrich). Semi-thin sections were visualized 
with slide-scanner Axio Scan.Z1 Zeiss, Objective Plan Apochromat 40x, NA 
0.95 air (Zeiss Germany). Immunofluorescence sections were either 
visualized with a confocal laser scanning microscope (Zeiss LSM 700, Carl 
Zeiss) or a Leica DFC490 charged coupled device camera attached to a Leica 
DM 6000 fluorescence microscope (Leica, Wetzlar, Germany). The confocal 
microscope pinhole was set at 1 Airy unit and pixel size at 90 nm and a 
40×/1.3 oil DIC M27 objective was used. Images were processed (overlays) 
using Adobe Photoshop and ImageJ software (http://rsb.info.nih.gov/ij/).  
 
Endocytic marker injection and tissue fluorescence measurement 
 Dextran-FITC 10 kDa (D1821, Molecular Probes) was used as fluid 
phase endocytosis marker and human recombinant transferrin (T3795, 
Sigma) was used as receptor-mediator endocytosis marker 32.  Dextran-FITC 
and human transferrin were diluted in the same isotonic saline solution (6.25 
mg/mL for dextran-FITC and 50 mg/mL for transferrin) and injected into the 
tail vein. Cytoplasmic fractions for kidney protein extraction were used for 
measuring FITC in the tissue with Nanodrop 3300 Fluorospectrometer 
(ThermoScientific). Samples were normalized for protein content and blanked 
with a sample from an animal that was not injected. 
 
Statistical analysis 
 
Statistical significances were calculated by student's t-test. P < 0.05 was 
considered significant. Results are presented as mean ± SEM. 
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Table 1 
 
 
  
Parameters Wt Sh 
Body weight (g) 303.8 ± 10.7 268.1 ± 18.7 
H2O intake (g/g BW) 0.13 ± 0.01 0.13 ± 0.01 
Food intake (g/g BW) 0.09 ± 0.01 0.09 ± 0.01 
   
Plasma   
pH 7.47 ± 0.01 7.51 ± 0.02 
Glucose (mg/dL) 225.8 ± 22.2 206.8 ± 16.6 
Na+ (mM) 136.5 ± 1.0 136.2 ± 0.3 
K+ (mM) 4.37 ± 0.15 3.62 ± 0.22 
Ionized Ca2+ (mM)    0.84 ± 0.14 0.80 ± 0.05 
Cl- (mM)                       97.8 ± 0.8 95.7 ± 0.6 
Phosphate (mg/dL) 8.6 ± 0.4 9.8 ± 0.3 * 
Prealbumin (mg/dL) 1.72 ± 0.31 1.53 ± 0.22 
Creatinine (mg/dL) 0.30 ± 0.02 0.40 ±  0.01 
BUN (mg/dL) 35.2 ± 1.0 48.3 ± 2.6 *** 
   
Urine   
Urine (g/g BW) 0.04 ± 0.01 0.03 ± 0.01 
Creatinine (mg/dL) 72.2 ± 10.3 111.9 ± 13.2 * 
Creatinine Clearance (g/min) 1.9 ± 0.2 1.5 ± 0.2 
Na+ (mM)/Crea (mg/dL) 95.0 ± 8.3 71.2 ± 22.8 ** 
K+ (mM)/Crea (mg/dL) 2.60 ± 0.11 2.73 ± 0.14 
Ca2+ (mM)/Crea (mg/dL) 0.020 ± 0.003 Not detectable 
Mg2+ (mg/dL)/Crea (mg/dL) 0.57 ± 0.10                                                 0.32 ± 0.15
Phosphate (mg/dL)/Crea(mg/dL) 0.08 ± 0.08 1.71 ± 0.20 *** 
Cl- (mM)/Crea (mg/dL) 2.2 ± 0.1 2.1 ± 0.1 
		
Table 2 
 
 
  
Parameters Wt/Pax8+ Flox/Pax8+ 
Body weight (g) 25.2 ± 1.0 23.6 ± 18.7 * 
H2O intake (g/g BW) 0.19 ± 0.02 0.26 ± 0.01 * 
Food intake (g/g BW) 0.16 ± 0.02 0.19 ± 0.01 
   
Plasma 
pH 7.26 ± 0.03 7.27 ± 0.05 
Glucose (mg/dL) 250.5 ± 8.9 238.9 ± 15.3 
Na+ (mM) 144.7 ± 1.1 146.0 ± 1.1 
K+ (mM) 3.9 ± 0.4 3.2 ± 0.1 * 
Ionized Ca2+ (mM)    0.96 ± 0.23 1.11 ± 0.05 
Cl- (mM)                       108.2 ± 1.5 109.2 ± 0.1 
Phosphate (mg/dL) 5.9 ± 0.1 6.2 ± 0.3 
Prealbumin (mg/dL) 1.76± 0.42 1.88± 0.15 
Creatinine (mg/dL) 0.05 ± 0.01 0.07 ±  0.01 
BUN (mg/dL) 40.6 ± 5.9 40.7 ± 3.3 
   
Urine 
Urine (g/g BW) 0.051 ± 0.009 0.083 ± 0.008 * 
Creatinine (mg/dL) 63.0 ± 4.2 42.8 ± 2.9 ** 
Creatinine clearance (mL/min) 1.09 ± 0.35 0.98 ± 0.23 
Na+ (mM)/Crea (mg/dL) 1.7 ± 0.2 5.8 ± 1.1 ** 
K+ (mM)/Crea (mg/dL) 6.0 ± 0.3 7.1 ± 0.3* 
Ca2+ (mM)/Crea (mg/dL) 0.03 ± 0.01 0.01 ± 0.21* 
Mg2+ (mg/dL)/Crea (mg/dL) 1.65 ± 0.10 1.70 ± 6.25 
Phosphate (mg/dL)/Crea(mg/dL) 6.7 ± 0.4 7.1 ± 0.6 
Cl- (mM)/Crea (mg/dL) 4.0 ± 0.2 5.0 ± 0.3 
		
FIGURE LEGENDS 
 
Figure 1.  Generation of the Atp6ap2 shRNA rat model and efficiency of 
Atp6ap2 / (P)RR) knock-down 
(A) Structure of the transgene construct, pTet-sh, made of two expression 
cassettes. A first one carries a tetracycline operator (tetO) sequence and 
expresses an shRNA against Atp6ap2 under the control of the human H1 
promoter. A second cassette consists of a tetracycline repressor (tetR) cDNA 
followed by a polyadenylation site (pA), and is driven by the CAGGS 
promoter. Primers TetOfw and CAGGSrv (arrows) were used for genotyping 
of rats. (B) Genotyping by PCR performed on newborn rat tails with a 195-bp 
PCR product characteristic of the transgenic animals (Sh). (C) Comparative 
expression of tetracycline repressor (TetR) protein between transgenic (Sh) 
and control (Wt) rats, as studied in various tissues by western blot. GAPDH 
was used as loading control. (D) RT-qPCR analysis of total mRNA of kidneys 
from rat Wt and Sh demonstrates successful knock-down of (P)RR/Atp6ap2 
mRNA (n = 6/genotype). (E) Immunohistochemistry for the H+ATPase a4 
subunit (green) and (P)RR (red)  in kidney sections  from Wt and Sh rats. 
Original magnification 400x. (F) Renal morphology of Sh and control animals. 
Semi-thin section (200 nm thick) were stained with Toluidine Blue (original 
magnification 40X) 
 
 
Figure 2.   Preserved fluid-phase endocytosis but impaired receptor-
mediated endocytosis in (P)RR/ATP6ap2 deficient rats 
(A) Albuminuria in Sh rats detected by coomassie blue staining of SDS-Page 
gels loaded with urine samples normalized to creatinine (7 mg/ml) BSA (7 mg 
/ml) was loaded as positive control. Bar graph summarizing data (n=4 in each 
animal group).  Student’s t-test  * p < 0.05. (B) Elevated vitamin D binding 
protein (VDBP) in urine of Sh rats detected by immunoblotting of urine 
samples normalized to creatinine (7 mg/ml). Urine from a Clcn5 KO mouse 
(C+) was loaded as positive control. Bar graph summarizing data from n = 
4/genotype. (C) Immunohistochemistry for dextran-FITC (10 kDa, green) and 
phalloidin (red) in kidney slices from Wt and shRNA rat 10 min. after injection 
(original magnification 400x). (D) Quantification of dextran-FITC in the 
		
cytoplasmic fraction of the control and Sh rats kidney homogenate. FITC-
dextran was normalized to total protein content. (E) Immunohistochemistry for 
human transferrin (red) and megalin (green) in Wt and Sh rats kidney 10 min 
and 40 min. after injection showed strong residual staining of transferrin after 
40 min in Sh rat kidneys (see insert) (original magnification 400x). (F) Western 
blotting for human transferrin in Wt and Sh rat urine 10 min. after injection. 
Urine samples were normalized to creatinine (7 mg/ml). Bar graph 
summarizing data from n = 4/genotype. (G) Western blotting of kidney total 
homogenate for human transferrin 10 and 40 min after injection. Statistical 
analyses were performed using Student’s t-test  ** p < 0.01. 
 
 
Figure 3.  Altered expression of proteins involved in receptor-mediated 
endocytosis 
(A) Brush border membrane preparations of control and Sh rats kidneys 
were used for blotting for H+ATPase a4 (ATP6Voa4), B2 (ATP6V1B2), and A 
(ATP6V1A) subunits as well as for NaPiIIa, NHE3, megalin, and cubilin. Total 
membrane protein kidney preparations were used for blotting of ClC-5. (B) 
Densitometries were adjusted to β-Actin (loading control).  Statistical analysis 
using Student`s t-test (n = 6/genotype or n = 4/genotype for NaPiIIa). * p < 
0.05 *** p ≤ 0.001. 
 
 
Figure 4.  Generation of kidney epithelial cell specific (P)RR/ATP6ap2 
ablation in mouse. 
(A) RT-qPCR analysis of total mRNA of kidneys, lungs and hearts from Wt 
and Flox /Pax8+ mice. Atp6ap2 mRNA abundance was normalized to HPRT. 
Statistical analysis was performed using Student’s t-test (Wt/Pax8+: n = 4 and 
Flox /Pax8+: n=5) ***  p < 0.001.  (B) Western blotting for (P)RR/ATP6ap2 in 
total membrane preparations from  kidney of Wt and Flox/Pax8+ mice and 
summary of data as bar graph. Statistical analysis was performed using 
Student’s t-test (Wt/Pax8+: n = 4 and Flox/Pax8+: n = 5) * p < 0.05. (C) 
Immunohistochemistry for (P)RR/ATP6ap2 (red), AQP2 (green) and DAPI 
(blue)  in kidney sections  from  Wt/Pax8 and  Flox/Pax8+ mice with proximal 
		
tubules (upper panels) and medullary collecting ducts (lower panels). Original 
magnification 400x. 
 
 
Figure 5.  Albuminuria and low molecular weight proteinuria in the 
absence of the (P)RR/ATP6ap2 
Urine samples were normalized to creatinine. Bovine serum albumin (BSA, 7 
mg/ml) or urine from a Clcn-5 KO mouse was loaded as positive control. (A) 
Albumin was detected by coomassie blue staining whereas (B) vitamin D 
binding protein (VDBP) or (C) (Pro)cathepsin B were revealed by 
immunoblotting. Data were summarized as bar graphs (n = 4/genotype. 
Student’s t-test ** p < 0.01, *** p < 0.001. 
 
 
Figure 6.   Delayed receptor-mediated endocytosis in (P)RR/ATP6ap2 
deleted mice 
WT/Pax8+ and Flox/Pax8+ mice were coinjected with dextran-FITC (10 kDa) 
and human recombinant transferrin and kidneys collected 10 and 40 min. after 
injection. (A) Immunohistochemistry for dextran-FITC,10 kDa (green) and 
phalloidin (red) in kidney slices from Wt and Flox/Pax8+ mice 10 and 40 min. 
after injection. (B) Immunohistochemistry for human transferrin (red) and 
megalin (green) in kidneys from Wt and Flox/Pax8+ mice 10 and 40 min. after 
injection. (C) Immunohistochemistry for Lamp-1 (green) and human transferrin 
(red) 40 min. after injection. Original magnification 400x.  
 
 
Figure 7.  Deletion of the (P)RR/ATP6ap2 alters expression of major 
proteins in the endocytic pathway. 
(A) Brush border membrane preparations from kidneys of Wt/Pax8+ and 
Flox/Pax8+ mice were blotted for the H+ATPase a4 (ATP6V0a4), a2 
(ATP6V0a2), EII (ATP6V1EII), B2 (ATP6V1B2) and A (ATP6V1A) subunits as 
well as for NHE3, megalin and cubilin. Total membrane protein kidney 
preparations were used for the western blot of ClC-5. (B) Densitometries were 
normalized to β-Actin (loading control).  Student`s t-test (n = 4 per group), * p 
≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 
		
 
 
Figure 8. Down-regulation of the mTOR pathway in (P)RR/ATP6ap2 
deficient mice and accumulation of autophagosomes 
(A, B) Western blotting for total and phosphorylated mammalian target of 
rapamycin (mTOR) and S6 kinase (S6K) and (B) densitometry summarizing 
results.  Student`s t-test (n = 4 per group), * p ≤ 0.05. (C) 
Immunohistochemistry for Microtubule-associated proteins 1A/1B light chain 
3B (LC3-B) (red) in kidneys from Wt and Flox/Pax8+ mice. Original 
magnification 400x.  
 
 
Supplementary figure legends 
 
Table 1. Metabolic and urine parameters from Wt and Sh rats.  
Water and food intake and also urine volume were monitored in metabolic 
cages under baseline conditions. After adaptation, 24-hrs urine and blood was 
collected for analysis. Statistical analysis were performed using Student’s t-
test (n=6/ genotype) * p < 0.05, ** p < 0.01, ***  p < 0.001.  
 
Table 2. Metabolic and urine parameters of Wt and Flox/Pax8+ mice.  
Water and food intake were monitored in metabolic cages under baseline 
conditions. 24-hrs urine and blood was collected for analysis. Statistical 
analysis were performed using Student’s t-test (n=8 in both groups) * p < 
0.05, ** p < 0.01, *** p < 0.001.  
 
Supplementary figure 1.  Dextran-FITC staining intensity and localization 
is similar in both animal groups at 10 min. and 40 min. time points. 
Immunohistochemistry for dextran-FITC, 10 kDa (green) and phalloidin (red) 
in kidney slices from Wt and shRNA rats 10 and 40 min. after injection. 
Original magnification 400x. 
 
 
		
Supplementary figure 2.  Cubilin localization in control and shRNA rat 
kidneys. 
Immunohistochemistry for cubilin (green) in kidney slices from Wt and shRNA  
rats. Original magnification 400 x. 
 
Supplementary figure 3.  Detection of (P)RR/ATP6ap2 in mouse kidneys 
with antibodies from Novus Biologicals. 
Kidneys from wildtype (Wt/ Pax8+)(A-C) and Flox/Pax8+ (D-F) mice were 
stained with antibodies from Novus Biologicals against the (P)RR/ATP6ap2 
(green), AQP2 (red), and with DAPI (blue) to detect nuclei. In wildtype kidney, 
strong staining with antibodies against the (P)RR/ATP6ap2 was detected in 
proximal tubules and in collecting ducts, in Flox/Pax8+ kidney, staining was 
weaker in the proximal tubule but preserved in collecting ducts. Of note, all 
cell types in the collecting duct were stained. Original magnification 400-630 
x. 
 
Supplementary figure 4.  Detection of (P)RR/ATP6ap2 in mouse kidneys 
with antibodies from R&D Systems. 
Kidneys from wildtype (Wt/ Pax8+)(A-B) and Flox/Pax8+ (C-D) mice were 
stained with antibodies from R&D Systems against the (P)RR/ATP6ap2 
(green), AQP2 (red), and with DAPI (blue) to detect nuclei. In wildtype kidney, 
strong staining with antibodies against the (P)RR/ATP6ap2 was detected in 
proximal tubules and in collecting ducts, in Flox/Pax8+ kidney, staining in the 
proximal tubule and collecting ducts remained unchanged. In contrast to 
staining with other antiobodies, staining with R&D Systems antibodies was 
mostly intracellular. Original magnification 400-630 x. 
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5. Discussion and outlook 
The renin-angiotensin system (RAS) is a hormonal system that 
regulates blood pressure by controlling fluid volume and vascular tone. The 
RAS system is activated when there is a drop in blood pressure or a drop in 
extracellular body fluid volume. This system is a pharmacological target for 
the most common drugs used for hypertension and cardiovascular diseases. 
Drugs like renin inhibitors (aliskiren), angiotensin-converting enzyme (ACE) 
inhibitors (captopril), angiotensin II receptor type 1 (AT1) antagonist (losartan) 
or mineralocorticoid receptor blockers (spironolactone) are widely prescribed 
125. The RAS is activated by the conversion of prorenin by proteolytical 
removal of its pro-segment into its active form renin. Renin then converts 
angiotensinogen into angiotensin I (AngI), representing the rate limiting step in 
the RAS system. Subsequently, AngI is further cleaved by the angiotensin-
converting enzyme (ACE) to give origin to angiotensin II (AngII) 125. This 
system was considered the classic RAS or systemic RAS in which prorenin 
was viewed as an inactive precursor. This concept was challenged by 
evidence pointing to a local RAS in several organs that seemed to work 
independently from the systemic RAS. Furthermore, upon blocking of several 
RAS components it was observed that plasma renin but also prorenin 
increased 125. Hypertension and diabetes also cause a rise of plasma levels of 
both renin and prorenin 126,127. Furthermore, in another study using transgenic 
mice, it was shown that prorenin was activated in pituitary glands in a non 
proteolytic fashion 128.  
In the sequence of these events, the (Pro)renin receptor or (P)RR was 
discovered in 2002 by Nguyen et al. as a membrane protein that could bind 
both renin and prorenin 62. They found that prorenin could also become 
activated through a conformational change leading to initiation of the RAS 
system. In addition to the activation of RAS and Ang II production, binding of 
renin/prorenin to (P)RR stimulates signaling pathways like ERK1/2 or MAP 
kinase independent from AngII production 75,129,130. Importantly, the affinity for 
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renin and prorenin to the (P)RR is in the nanomolar range for both while under 
physiological conditions their concentration is in the picomolar range (≅ 0.5 
pmol/L for renin and ≅ 5pmol/L for prorenin) 131,132. Also, attempts to generate 
(P)RR full knockout mouse failed while knockouts models for other RAS 
members were generated successfully 133,134. These discordant data together 
with evidence that (P)RR is expressed in animals lacking a functional RAS 
system such as Drosophila and Zebra fish suggests that (P)RR has more 
fundamental functions not related to the RAS. Furthermore, (P)RR was found 
to be identical to a protein M8-9 that was co-purified together with H+-
ATPases from chromaffin cells 62,69. Hence, in the last 6 years the (P)RR field 
is moving towards understanding the fundamental functions of the 
(P)RR/ATP6ap2. Since then, the (P)RR was found to be important in Wnt 
signaling 81,117, for podocyte 118,120,135 and cardiomyocyte 116 function but also 
for lysosomal and autophagy function 117,119,136. These studies together with 
immunoprecipitation and immunohistochemistry studies indicate that 
(P)RR/ATP6ap2 is physically coupled to H+-ATPases 64,81,115. In this context, 
this thesis addresses a timely question in the research focus of 
(P)RR/ATP6ap2 functions related to H+-ATPases. We were particularly 
interested in studying this potential partnership in the kidney where H+-
ATPases are highly expressed. 
In chapter 1, our study expands earlier observations on 
(P)RR/ATP6ap2 expression in the murine kidney. Our results demonstrate 
that (P)RR/ATP6ap2 has higher expression in the collecting duct, specifically 
in IC. Furthermore, with regard to (P)RR/ATP6ap2 localization in IC subtypes, 
(P)RR/ATP6ap2 follows H+-ATPase plasma membrane localization. The 
same applies for PT localization. By placing mice on different diets known to 
affect H+-ATPase abundance and subcellular localization we looked whether 
H+-ATPase expression and trafficking also has a parallel effect on 
(P)RR/ATP6ap2. Using a combination of mRNA and protein expression 
studies we found no evidence for coordinated regulation of mRNA/ protein of 
(P)RR/ATP6ap2 and H+-ATPase subunits a4 and B1. On the other side, 
immunohistochemistry showed that (P)RR/ATP6ap2 co-localizes with the V-
ATPase subunit a4 to a  high degree in IC-type A (basolateral staining for 
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Ae1) and IC- type B or non-A non-B (negative staining for Ae1) following H+-
ATPase trafficking upon different diets/treatments. In a last set of experiments 
we addressed the question whether prorenin would acutely affect basal H+-
ATPase function in type A intercalated cells. We address this question by 
performing microperfusion experiments in murine isolated cortical collecting 
ducts exposed to different prorenin concentrations and examined H+-ATPase 
activity (measured as pHi recovery rates after intracellular acidification with a 
NH4Cl prepulse). We also checked for (P)RR/ATP6ap2 signaling output by 
looking at  phosphorylation of ERK1/2 in MDCK cell and in freshly isolated 
collecting ducts. Prorenin had no effect on basal H+-ATPase activity and 
ERK1/2 phosphorylation indicating that prorenin is not directly regulating H+-
ATPase activity. Therefore, we could rule out a relevance of acute prorenin for 
the regulation of H+-ATPase activity which seems to be independent of the 
role of (P)RR/ATP6ap2 in the RAS. Also, our work suggests that H+-ATPase  
trafficking does seem to be paralleled by (P)RR/ATP6ap2 trafficking. We have 
to consider that we only look at a4 and B1 H+-ATPase subunits. Therefore, 
our  observations can be due to this H+-ATPase subunits composition. This 
work does not address the potential functional relevance of (P)RR/ATP6ap2 
for PT or IC function. 
In chapter 2, we investigated the function of the (P)RR/ATP6ap2  in the 
PT using two different animal models. A rat model with an inducible shRNA 
for Atp6ap2 and an inducible kidney epithelial cell-specific knockout mouse for 
(P)RR/ATP6ap2. The rat model was a full knockdown of (P)RR/ATP6ap2 
which means that (P)RR/ATP6ap2 expression was also abrogated in the 
podocytes. The inducible kidney epithelial cell-specific knockout mouse model 
bypassed the problems of a full knockdown of (P)RR/ATP6ap2 and in 
particular in the podocytes, resulting in a better model to study PT. 
Furthermore, our mild induction protocol for the mouse model led to a 
successful knockout for (P)RR/ATP6ap2 in the PT but only partial knockout in 
the IC. With a milder induction we circumvented doxycycline kidney side 
effects and also avoided IC cells phenotype already described in previous 
studies 72,73,137. In this manner, we could better focus on study 
(P)RR/ATP6ap2 function in the PT. In this study, we revealed that 
	 41 
(P)RR/ATP6ap2 plays a role in receptor-mediated endocytosis and lysosomal 
function in the proximal tubule. Both Atp6ap2-Sh rats and 
Flox(P)RR/Pax8Cre+ mice showed excretion of albumin and low molecular 
weight proteins in urine, delayed processing of substrates of the receptor-
mediated endocytosis pathway, reduced expression of other key molecules 
involved in this process as well as downregulation of the mTOR pathway and 
accumulation of the LC3B subunit of the autophagosome.  
Furthermore we observed reduced expression of several H+-ATPase 
subunits including the a4 subunit (ATP6V0a4) in Atp6ap2-Sh rats and 
knockout mice. The chloride/proton exchanger ClC-5 had reduced expression 
in knockout mice while in the Atp6ap2-Sh rats was increased. Both H+-
ATPase and ClC-5 are known to be important for endosomal pathway 
acidification, suggesting impairment in the acidification of endosomes and 
lysosomes. Lysosomal dysfunction is also suggested by altered mTOR 
signaling and accumulation of LC3B, a marker for autophagy.  It still remains 
unclear, whether the observed effects are caused by (P)RR/ATP6ap2 deletion 
and/or are a direct consequence of endosome/ lysosome defects. 
This study confirms the role of the (P)RR/ATP6ap2 in autophagy 
already observed in podocytes 118,120 and cardiomyocytes 116, by showing it in 
a different cell type, in PT epithelial cells. In fact, this was the first study 
assessing the role of the (P)RR/ATP6ap2 role in PT function. Although we 
described a specific defect in receptor-mediated endocytosis and suggested 
that this defect may be due to acidification problems. It would be interesting to 
actually measure lysosomal pH in (P)RR/ATP6ap2 transgenic models. This 
could be done by performing a	 functional study by measuring lysosome 
activity (by using DQ-albumin for example) and lysosome acidification (by 
using Lysotracker) in isolated PT or primary cells by microperfusion.  
We could not explain why there is no defect in the expression or 
localization of megalin and cubulin, the multispecific receptors involved in 
receptor-mediated endocytosis. Megalin and cubilin are responsible for 
reabsorbing transferrin, albumin, vitamin D binding protein and procathepsin 
B, ligands that were found in the urine of (P)RR/ATP6ap2 transgenic animals. 
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Furthermore, both megalin and cubulin, after releasing their respective ligands 
in the early endosome, are recycled back to the plasma membrane. In the 
case of an impairment of endocytic acidification, the release of ligands from 
their receptors is also delayed. Accordingly, CLC-5 KO mice, had an impaired 
endocytic uptake due to a decreased expression of megalin and cubilin in PT 
BBM 53. Also, rapamycin chronically treated mice (inhibition of mTORC1) 
showed LMW proteinuria consistent with lower expression of megalin in the 
PT 102. Similarly, animal models of cystinosis displayed LMW proteinuria 
related to a reduced expression of megalin and cubilin in the PT 58,138.  
 It is important to note that (P)RR/ATP6ap2 knockdown or knockout 
leads to a mild defect which could be due to residual expression of 
(P)RR/ATP6ap2 in both animal models. In the case of flox(P)RR/Pax8Cre+ 
mice although most of the (P)RR/ATP6ap2 is deleted in the PT, it was still 
expressed in the IC.. 
 As mentioned above, upon (P)RR/ATP6ap2 downregulation or 
deletion, only a few H+-ATPase subunit isoforms were affected. It is also 
important to note, that the (P)RR/ATP6ap2 does not have a homolog in 
unicellular organisms like yeast where H+-ATPase is functional and well 
characterized. This suggests that the (P)RR/ATP6ap2 is not essential for all 
types of H+-ATPases 116,139. It may be that the (P)RR/ATP6ap2 does not 
participate in all H+-ATPase functions and that plasma membrane function 
and intracellular membrane function should be addressed separately. One 
should also keep in mind an important observation from our studies in 
Chapter 1 where we demonstrate that (P)RR/ATP6ap2 and H+-ATPase do not 
seem to be regulated in parallel in all situations. When we used Atp6ap2-Sh 
Rats and Flox(P)RR/Pax8Cre+ mice, we see only a defect in receptor-
mediated endocytosis but not in fluid phase endocytosis. Also, we cannot 
discard the idea that lysosomal and autophagy defects resulting from 
(P)RR/ATP6ap2 knockdown or knockout could be a consequence of cellular 
defects, instead of a direct effect of impaired H+-ATPase expression or 
function. Another open question that remains to be addressed is what is the 
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mechanism through which (P)RR/ATP6ap2 is important for H+-ATPase 
function.  
The body of work covered in the current thesis sheds new light on the 
role of the (P)RR/ATP6ap2 in intracellular organelles in PT. However, further 
experiments are required to fill the knowledge gap in the field. The 
mechanistic basis for (P)RR/ATP6ap2 would be an essential first step towards 
understanding its role in the regulation of H+-ATPase function.  
In the (P)RR/ATP6ap2 field it is becoming clear that (P)RR functions 
go beyond the RAS regulation. The (P)RR/ATP6ap2 is important for cellular 
homeostasis by regulating H+-ATPase activity. With our work we build on the 
work already done in kidney to understand the role of the (P)RR/ATP6ap2 in 
this organ 64,118,120 and also extend the knowledge on the role of the (P)RR/ 
ATP6ap2 in intracellular trafficking. Our data also suggests that this role of 
(P)RR/ATP6ap2 could be via H+-ATPase regulation. The identity of the H+-
ATPase subtypes and the mechanism(s) underlying (P)RR/ATP6ap2 effects 
on H+-ATPase function needs to be determined.  
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